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Abstract
The b1-adrenergic signaling system plays an important role in the functioning of cardiac cells. Experimental data shows that
the activation of this system produces inotropy, lusitropy, and chronotropy in the heart, such as increased magnitude and
relaxation rates of [Ca2+]i transients and contraction force, and increased heart rhythm. However, excessive stimulation of
b1-adrenergic receptors leads to heart dysfunction and heart failure. In this paper, a comprehensive, experimentally based
mathematical model of the b1-adrenergic signaling system for mouse ventricular myocytes is developed, which includes
major subcellular functional compartments (caveolae, extracaveolae, and cytosol). The model describes biochemical
reactions that occur during stimulation of b1-adrenoceptors, changes in ionic currents, and modifications of Ca2+ handling
system. Simulations describe the dynamics of major signaling molecules, such as cyclic AMP and protein kinase A, in
different subcellular compartments; the effects of inhibition of phosphodiesterases on cAMP production; kinetics and
magnitudes of phosphorylation of ion channels, transporters, and Ca2+ handling proteins; modifications of action potential
shape and duration; magnitudes and relaxation rates of [Ca2+]i transients; changes in intracellular and transmembrane Ca2+
fluxes; and [Na+]i fluxes and dynamics. The model elucidates complex interactions of ionic currents upon activation of b1adrenoceptors at different stimulation frequencies, which ultimately lead to a relatively modest increase in action potential
duration and significant increase in [Ca2+]i transients. In particular, the model includes two subpopulations of the L-type
Ca2+ channels, in caveolae and extracaveolae compartments, and their effects on the action potential and [Ca2+]i transients
are investigated. The presented model can be used by researchers for the interpretation of experimental data and for the
developments of mathematical models for other species or for pathological conditions.
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comprehensive models for b1-adrenergic system in ventricular
myocytes of different species [8,9,10,11,12]. The first model
developed by Saucerman et al. [10] for rat ventricular myocytes
set high standards for simulation of the b1-adrenergic signaling
system. The model included biochemical and electrophysiological
parts with two major protein kinase A targets, phospholamban and
the L-type Ca2+ channel, and consisted of one cytosolic
compartment (single-compartment model). Later, a similar model
was developed for rabbit ventricular myocytes and included
several new PKA targets: ryanodine receptors, troponin I, and
slow delayed rectifier K+ current, IKs [11]. The model was further
extended to simulate the effects of the b1-adrenergic signaling
system in mouse ventricular myocytes, predominantly on Ca2+
dynamics [12]. Finally, a model of b1-adrenergic signaling system
in guinea pig ventricular myocytes [9] was developed based on the
model of Saucerman et al. [10], which is devoted to the analysis of
the changes in action potential, intracellular [Ca2+]i transients, and
ionic fluxes upon stimulation of b1-adrenoceptors with agonist
isoproterenol.

Introduction
Cardiac cells belong to a wide class of excitable cells which
include electrical activity, Ca2+ dynamics, and protein signaling
networks. While early experimental studies of cardiac cells are
predominantly devoted to their electrical activity, and later to Ca2+
dynamics, more recent studies involve investigations of protein
signaling systems, which modulate both action potentials and
intracellular Ca2+ transients [1,2]. On the tissue and whole heart
levels, the activation of such signaling systems either promotes or
suppresses pro-arrhythmic behavior. In addition, in diseased
hearts, protein signaling networks become modified and do not
properly regulate the electrical activity or Ca2+ handling system
[3]. As a result, the studies of major signaling protein networks in
cardiac cells identified new potential therapeutic targets for
treatment of heart diseases; some of the targets include signaling
proteins involved in b1-adrenergic signaling system [4,5,6,7].
Mathematical modeling of protein signaling networks is a
supplementary tool for understanding their functions in the heart.
Recently, particular attention has been paid to the development of
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relatively moderate AP prolongation, significant increase in
intracellular [Ca2+]i transients, modification of the intracellular
and transmembrane Ca2+ fluxes, and [Na+]i fluxes and dynamics.
The model includes two pools of the L-type Ca2+ channels, one in
the caveolae and the other in the extracaveolae compartments.
The simulations demonstrated their different modulations upon
stimulation of b1-ARs and their different effects on the action
potentials and [Ca2+]i transients. The model simulated frequency
dependences of [Ca2+]i transient decays for control conditions and
after stimulation of b1-ARs, and made testable predictions for the
frequency dependences of [Ca2+]i transient amplitudes, AP
amplitudes and durations. The simulation results are compared
to the results obtained from other models of b1-adrenergic
signaling system in other species, and the model limitations are
discussed.

Simultaneously, multi-compartmental models of protein signaling networks, including the b1-adrenergic signaling system, were
developed [8,13,14]. The compartmentalized models of Iancu
et al. [13,14] included only the biochemical part of b1-adrenergic
and M2-muscarinic signaling systems and described the dynamics
of cAMP and PKA in different subcellular compartments
(caveolae, extracaveolae, and cytosol). The only compartmentalized model of cardiac protein signaling network, which includes
both biochemical and electrophysiological parts, b1- and b2adrenergic and CaMKII-mediated signaling systems, was developed recently for canine ventricular myocytes by Heijman et al.
[8]. The model was extensively verified by experimental data and
reproduced major features of stimulation of the three signaling
systems.
Compartmentalization of the signaling systems in cardiac cells is
an important property. This property allows for regulation of
multiple cellular functions, such as electrical activity, Ca2+
dynamics, and cellular contraction (for examples see reviews
[1,15,16,17,18]). The experimental data demonstrates differential
localization of the components of the Ca2+-mediated, a- and badrenergic signaling systems [19,20,21,22]. In cardiac myocytes,
b1-adrenergic receptors are mostly localized in membrane
compartments that lack caveolin-3, while b2-adrenergic receptors
are mostly found in caveolin-3-rich domains [20]. Investigations of
the physiological role of the b-receptors have shown their differing
effects in the development of disease states: excessive activation of
b1-adrenergic signaling led to cardiac hypertrophy and heart
failure [23], while moderately increased stimulation of b2adrenergic signaling was cardioprotective [24]. In addition, b1and b2-adrenergic receptors modulate differently cardiac ionic
currents and contraction proteins, which are also localized in
different cellular compartments [15,16]. In the b1-adrenergic
signaling system alone, which is the major topic of this paper,
multiple signaling molecules are also distributed among the major
cellular compartments related to caveolin-3, non-caveolae cellular
membrane, or cytosol, and these molecules are differentially
modulated upon activation of b1-receptors. In particular, the
recent discovery of the two subpopulations of the L-type Ca2+
channels, the major players in cardiac excitation-contraction
coupling, which are localized in caveolin-3-rich and non-caveolae
compartments and play different physiological roles, requires more
comprehensive, compartmentalized models of cardiac cells [22].
In this paper, we developed a new compartmentalized model
for the b1-adrenergic signaling system in mouse ventricular
myocytes. The model is based on our previously published models
for action potential and Ca2+ dynamics in mouse ventricular
myocytes [25,26]. The new model includes both biochemical and
electrophysiological parts, as well as compartmentalization of the
b1-adrenergic signaling system, which includes three major
compartments: caveolae, extracaveolae, and cytosol. Both biochemical and electrophysiological parts are verified by extensive
experimental data, primarily obtained from the rodent cardiac
cells. Activation of the major proteins in the signaling system, such
as adenylyl cyclases and phosphodiesterases, is compared directly
to the data from the mouse ventricular myocytes in absolute
magnitudes. The model successfully reproduced existing experimental data on cAMP dynamics, activation of adenylyl cyclases
and phosphodiesterases, protein kinase A and phosphorylation of
its targets, and the effects of phosphodiesterases inhibition on
cAMP transients. Simulations also reproduced data obtained from
voltage-clamp protocols for major repolarization currents of
mouse ventricular myocytes. The model is able to simulate action
potential shape and duration upon stimulation of b1-adrenergic
receptors (b1-ARs). The model elucidated the mechanism of
PLOS ONE | www.plosone.org

Methods
A mathematical model for the b1-adrenergic signaling system in
mouse ventricular myocytes is a natural extension of the previously
published model for action potential and Ca2+ dynamics in mouse
ventricular myocytes [25], with model improvements from [26]
(Fig. 1). We incorporated a b1-adrenergic signaling pathway in our
model of electrical activity and Ca2+ handling with modifications
[25,26] (see Appendix S1).
Our model cell consists of several compartments (Fig. 1;
Appendix S1). For the b1-adrenergic signaling system we consider
three major functional compartments: caveolae (cav), extracaveolae
(ecav), and cytosol (cyt) [8,13]. The caveolae compartment is a
submembrane compartment associated with the protein caveolin3. The extracaveolae compartment is also a submembrane
compartment associated with cholesterol-rich lipid rafts, but it
does not include caveolin-3. Both caveolae and extracaveolae
compartments together represent the particulate fraction. The
cytosolic compartment (the soluble fraction) represents the rest of
the cell volume, excluding mitochondria. As the dynamics of Ca2+
concentration does not directly depend on the b1-adrenergic
signaling system, we use the same compartmentalization of Ca2+
handling as in Bondarenko et al. [25]. The subspace volume (Vss)
of the Ca2+ handling system is completely located in the
extracaveolae compartment of the b1-adrenergic signaling system.
Total protein concentrations and their activities are normalized
to the cell volume as in [8]. In most cases, we used Table 9 from
[27] to convert protein concentrations from pmol/mg cell protein
to the concentrations in mM. The localization of different signaling
proteins and protein kinase A substrates in subcellular compartments can be found in Fig. 1 and Appendix S1 and will be
described below in the corresponding chapters. The experimental
data in the Methods chapter are used for constraining the model;
the experimental data in the Results chapter are used for testing
the developed model. The latter experimental data were not used
for constraining the model.
In all compartments, the b1-adrenergic signaling system is
activated by agonist (isoproterenol) (Fig. 1). Stimulation of b1-ARs
leads to activation of the stimulatory G protein, Gs, which
dissociates into Gsa and Gsbc subunits. Both subunits activate
adenylyl cyclases (AC5/6 or AC4/7, depending on the cellular
compartment), which produce cyclic AMP. cAMP is degraded by
phosphodiesterases, three isoforms of which, PDE2, PDE3, and
PDE4, are included in our model. Balanced activities of ACs and
PDEs establish steady-state levels of cAMP in different compartments. cAMP further activates protein kinase A holoenzyme,
which consists of two regulatory and two catalytic subunits.
Binding four cAMP molecules to PKA holoenzyme causes
2
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Figure 1. Schematic representation of the b1-adrenergic signaling system in mouse ventricular myocytes. Transmembrane currents are
the fast Na+ current (INa), the two components of the L-type Ca2+ current in caveolae and extracaveolae compartments (ICaL,cav and ICaL,ecav,
respectively), the sarcolemmal Ca2+ pump (Ip(Ca)), the Na+/Ca2+ exchanger (INaCa), the rapidly recovering transient outward K+ current (IKto,f), the rapid
delayed rectifier K+ current (IKr), the ultrarapidly activating delayed rectifier K+ current (IKur), the noninactivating steady-state voltage activated K+
current (IKss), the time-independent K+ current (IK1), the Na+/K+ pump (INaK, is regulated by phospholemman, PLM), the Ca2+ and Na+ background
currents (ICab and INab). The Ca2+ fluxes are uptake of Ca2+ from the cytosol to the network sarcoplasmic reticulum (NSR) (Jup) by the SERCA pump and
Ca2+ release from the junctional sarcoplasmic reticulum (JSR) (Jrel) through the ryanodine receptors (RyRs). There are three intracellular compartments
in the b1-adrenergic signaling system: caveolae, extracaveolae, and cytosol. The subspace volume (Vss) is located in the extracaveolae domain.
Components of the b1-adrenergic signaling system are the b1-adrenergic receptors (b1-AR), the a-subunit of stimulatory G-protein (Gsa), the
bc-subunit of stimulatory G-protein (Gbc), the adenylyl cyclases of type 5/6 or 4/7 (AC5/6 or AC4/7, respectively), the phosphodiesterases of type 2, 3,
or 4 (PDE2, PDE3, or PDE4, respectively), the cyclic AMP (cAMP), regulatory (R) and catalytic (C) subunits of protein kinase A holoenzyme, the protein
kinase A inhibitor (PKI), the G-protein-coupled receptor kinase of type 2 (GRK2), the protein phosphatases of type 1 or 2A (PP1 or PP2A, respectively),
the inhibitor-1 (I-1). The cytosolic proteins which are the substrates of the b1-adrenergic signaling system are the phospholamban (PLB) and troponin
I (TnI). Stimulatory links are shown by black arrows and inhibitory links are shown by red dashed lines with balls. [Ca2+]i, [Na+]i, and [K+]i are the
intracellular Ca2+, Na+, and K+ concentrations in the caveolae, extracaveolae, and cytosol; [Ca2+]o, [Na+]o, and [K+]o are the extracellular Ca2+, Na+, and
K+ concentrations.
doi:10.1371/journal.pone.0089113.g001

dissociation of two catalytic subunits that phosphorylate target
proteins, among them are PDE3 and PDE4. b1-ARs are
phosphorylated by PKA, as well as by G protein coupled receptor
kinase of type 2 (GRK2). PKA is also regulated by heat-stable
protein kinase inhibitor (PKI). Intracellular proteins are dephosphorylated by two types of phosphatases, protein phosphatase 1
and 2A. PKA target proteins are located in different compartments. In our model, 20% of the L-type Ca2+ channels (the L-type
Ca2+ current, ICaL), the fast Na+ current, INa, and the phospholemman, which regulates the Na+-K+ pump, INaK, are localized in the
caveolae compartment; 80% of the L-type Ca2+ channels, the
ryanodine receptors, RyRs, the ultra-rapidly activating delayed
rectifier K+ current, IKur, the rapidly inactivating transient
outward K+ current, IKto,f, and the time-independent K+ current,
IK1, are localized in the extracaveolae compartment; and
phospholamban and troponin I are localized in the cytosolic
compartment (more details are shown below).
PLOS ONE | www.plosone.org

Model Development: Biochemical Part
b1-adrenergic receptor module. According to the experimental findings [19,20,28], the vast majority of b1-adrenergic
receptors are located in non-caveolae fractions. The estimated
total concentration of b1-ARs in mouse ventricular myocytes is
0.0103 mM [29]. In our model, we distribute the b1-ARs almost
evenly between the extracaveolae and cytosolic compartments,
with only 1% located in the caveolae compartment (see Appendix
S1). Such distribution of b1-ARs allowed us to obtain in the model
approximately equal cAMP transients in the caveolae and
extracaveolae compartments, which is in line with the measurements of local cAMP concentrations in similar compartments in
rat and mouse ventricular myocytes [30]. In the b1-adrenergic
receptor module, we separate relatively fast biochemical reactions
(ligand-receptor and G-protein-receptor interactions, with time
scales of tens milliseconds [31]), which are described by algebraic
equations in steady-state approximation, and slower reactions
3

February 2014 | Volume 9 | Issue 2 | e89113

Adrenergic Signaling in Mouse Myocytes

agonist isoproterenol increased the phosphorylation level of b1ARs by about 108% (Fig. 2), which is reproduced by our model.
Moreover, about 30% of phosphorylation of b1-ARs occurs by
GRK2, as it is found from the suppression of PKA by H-89 (Fig. 2).
Our model is also able to reproduce this effect.
Adenylyl cyclase module. In a b1-adrenergic pathway,
adenylyl cyclases are responsible for synthesis of cAMP from
ATP. Our model includes four major types of adenylyl cyclases
(AC) found in mouse ventricular myocytes, AC4, AC5, AC6, and
AC7 [33,34]. Two of them, AC5 and AC6, are located in caveolae
and have similar properties (we denote them as AC5/6) [35]. Two
others, AC4 and AC7, also have similar properties: they do not coimmunoprecipitate with caveolin-3 and they are excluded from
caveolae (we denote them as AC4/7) [13,28,36].
We simulated activation of adenylyl cyclases by the a-subunit of
G-protein, Gsa, [8,13] (see Appendix S1). In addition, we
considered the stimulation of adenylyl cyclases AC5/6 and
AC4/7 by bc-subunit, Gsbc, according to the experimental data
[37,38,39,40]. The total amount of adenylyl cyclases in a cardiac
cell is estimated as 0.02622 mM [41], with 74% of AC5/6 type [8].
Figure 3A shows experimental data on activation of AC5 and
AC6 by Gsa [37] and corresponding simulation data using our
model for AC5/6 activation. In Fig. 3B, simulation data on
activation of AC4/7 by Gsa is compared to the experimental data
for AC4 [38,40]. Figures 3C and 3D compare the experimental
data from [39,40] to our simulations for the dependence of AC5/6
and AC4/7 activities on Gsbc. Both figures show good agreement
between the experimental and simulated results.
We also simulated the effects of different concentrations of
b1-adrenoceptor agonist isoproterenol on adenylyl cyclase activity
in mouse ventricular myocytes (Fig. 4A). Experimental data on
total AC activity in mouse ventricles and cardiac cells as a function
of isoproterenol concentration after 10-min exposures are shown
by unfilled [42] and filled circles [43] with error bars. Simulation
data on AC activity at the 10th minute after the exposure to
different concentrations of isoproterenol are shown by a solid line.
As seen in Fig. 4A, our model was able to reproduce absolute
values of the total cellular adenylyl cyclase activity as a function of
isoproterenol.

(G-protein activation (hundreds milliseconds [31]), PKA- and
GRK2-mediated phosphorylation (hundreds seconds [31]; GRK2,
G-protein-coupled receptor kinase of type 2)), which are described
by ordinary differential equations (see Appendix S1).
In order to derive algebraic equations which describe ligandreceptor and G-protein-receptor interactions in the caveolae
compartment (equations (A.7)-(A.11) in the Appendix S1),
we consider mass conservation laws for non-phosphorylated
b1-adrenergic receptors and G-proteins in that compartment:
cav
cav
cav
cav
½Rb1 cav
np,tot ~½LRb1 np z½LRb1 Gs np z½Rb1 Gs np z½Rb1 np,f ,

cav
cav
cav
½Gs cav
abc ~½LRb1 Gs np z½Rb1 Gs np z½Gs f ,

ð1Þ

ð2Þ

where ½Rb1 cav
np,tot is the total concentration of non-phosphorylated
(np) b1-ARs in the caveolae compartment, ½LRb1 cav
np is the
concentration of b1-ARs with bound ligand L (concentration
[L]), ½LRb1 Gs cav
np is the concentration of b1-ARs with bound ligand
L and stimulatory G-protein Gs, ½Rb1 Gs cav
np is the concentration of
b1-ARs with bound Gs, ½Rb1 cav
is
the
concentration of free
np,f
b1-ARs, ½Gs cav
is
the
total
concentration
of the stimulatory
abc
G-protein Gs, and ½Gs cav
is
the
concentration
of free Gs.
f
,
½LRb1 Gs cav
Concentrations of complexes ½LRb1 cav
np
np , and
cav
½Rb1 Gs np can be obtained from the steady-state approximation
for corresponding biochemical reactions, provided that the related
dissociation constants are known (equations (A.12)-(A.14) in the
Appendix S1). The steady-state approximation for a chemical
reaction describes the formation of complex AB from the
substances A and B: A+B « AB. For this reaction, k+ and k2
are the forward and backward rates, respectively, and K is the
dissociation constant (K = k2/k+). The complex formation is
described by the differential equation d[AB]/dt = k+[A]?[B] 2
k2[AB], where [A], [B], and [AB] are the concentrations of the
substances A, B, and complex AB, respectively. In steady state,
d[AB]/dt = 0, therefore, k+[A]?[B] 2 k2[AB] = 0. From the
last equation, we can determine the concentration of complex
AB in the steady-state approximation: [AB] = [A]?[B]/(k2/
k+) = [A]?[B]/K.
cav
Substitution of the equation for ½LRb1 Gs cav
np , and ½Rb1 Gs np into
cav
equation (1) and solution with respect to ½Gs f yields equation
(A.11). Further substitution of the expressions for ½LRb1 cav
np ,
cav
cav
into equation (2) results in
½LRb1 Gs cav
np , ½Rb1 Gs np , and ½Gs f
equation (A.10). The complete system of algebraic equations for
ligand-receptor and G-protein-receptor interactions for the
caveolae, extracaveolae, and cytosolic compartments is given in
Appendix S1.
Activation of Gs-proteins, with dissociation of ½Gs cav
a,GTP and
cav
½Gs bc -subunits, occurs through a relatively fast process with
cav
½LRb1 Gs cav
np complex or a relatively slow process with ½Rb1 Gs np
cav
cav
cav
complex, and ½Gs a,GTP is hydrolyzed further to ½Gs a,GDP : ½Gs abc is
cav
formed back through re-association of ½Gs cav
a,GDP and ½Gs bc
(equations (A.17)-(A.19) in Appendix S1) [8,10].
Phosphorylation (desensitization) of b1-ARs occurs by both
protein kinase A and G-protein-coupled receptor kinase of type 2,
GRK2 [8,10] (equations (A.15) and (A.16) for the caveolae
compartment). PKA phosphorylates b1-ARs both in ligand- and
G-protein-bound states and unbound states, while GRK2 phosphorylation affects only ligand-bound states [8,10]. According to
the experimental finding [32], application of 10 mM of b1-ARs
PLOS ONE | www.plosone.org

Figure 2. b1-adrenoceptors phosphorylation. b1-adrenoceptors
phosphorylation above basal level after 15-minute application of 10 mM
isoproterenol or 10 mM isoproterenol+PKA inhibitor H-89. Experimental
data from Freedman et al. [32] are shown with black bars with errors,
simulation data are shown with gray bars. Effect of H-89 was simulated
by setting [PKA]tot = 0 mM.
doi:10.1371/journal.pone.0089113.g002
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Figure 3. Normalized activity of adenylyl cyclases as functions of Gsa and Gsbc. Panel A: Experimental normalized activity of AC5 (filled
circles) and AC6 (unfilled circles) as functions of Gsa [37]. Simulated data for normalized activity of AC5/6 is shown by a solid line. Panel B:
Experimental normalized activity of AC4 (filled circles from [40] and unfilled circles from [38]) as functions of Gsa. Simulated data for normalized
activity of AC4/7 is shown by a solid line. Panel C: Experimental normalized activity of AC5 (filled circles) [39] as functions of Gsbc. Simulated data for
normalized activity of AC5/6 is shown by a solid line. Panel D: Experimental normalized activity of AC4 (filled circles) [40] as functions of Gsbc.
Simulated data for normalized activity of AC4/7 is shown by a solid line.
doi:10.1371/journal.pone.0089113.g003

PDE4 into the caveolae and cytosolic compartments, and PDE2
and PDE4 into the extracaveolae compartment. Such distribution
fits available experimental data on their localization [46,47]. For
subcellular distribution of the PDE isoforms we used experimental
data obtained by Mongillo et al. [48] for rat ventricular myocytes,
and the parameters were adjusted to fit experimental data on
PDE2, PDE3, and PDE4 activities in mouse hearts [44,49].
PDE2, PDE3, and PDE4 are activated by cAMP molecules, but
with different affinities (see Appendix S1). In addition, phosphorylation of PDE3 and PDE4 increases their activities by several
folds. These processes are simulated by ordinary differential
equations derived for three subcellular compartments (caveolae,
extracaveolae, and cytosol, see Appendix S1). Our model also
tested the effects of non-specific PDE inhibitor 3-isobutyl-1methylxanthine (IBMX).
Figure 5A shows experimental and simulated absolute activities
of PDE2, PDE3, and PDE4 in mouse and rat hearts. There are
some differences in the magnitudes of experimental contributions
of different PDE isoforms in total cellular PDE activity obtained by
different research groups and between species. However, these

Adenylyl cyclase activity can also be used as an indicator of
desensitization of b1-ARs. Experimental data on AC activity as a
function of isoproterenol were obtained by Freedman et al. [32] at
three time moments after exposure to an agonist (at the maximum
activity (from 50th to 75th seconds, depending on isoproterenol
concentration), 5th min, and 30th min). It is shown that the AC
activity decreases in time, reflecting b1-ARs desensitization
(phosphorylation by PKA and GRK2) (symbols in Fig. 4B). Our
model satisfactory reproduced this phenomenon. Simulation data
also demonstrates the decrease in AC activity as a function of time
at different concentrations of isoproterenol (solid, dashed, and
dash-dotted lines in Fig. 4B).
Phosphodiesterase module. Phosphodiesterases in the
b1-adrenergic signaling system degrades cAMP into inert molecule
59-AMP. We included in our model three major types of
phosphodiesterases (PDE2, PDE3, and PDE4) found in mouse
ventricular myocytes [44]. While a significant amount of PDE1
was found in mouse ventricles, the study of Bode et al. [45] shows
that this type of PDE is predominantly located in non-myocyte
cells. As in previous models [8,13], we put PDE2, PDE3, and
PLOS ONE | www.plosone.org
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reproduce the partial contributions of different PDE isoforms into
the total PDE activity of particulate fraction (Fig. 5C). In this
figure, we used experimental data of Mongillo et al. [48] obtained
from rat cardiomyocytes.
The effects of the PDE inhibitor IBMX on cAMP production in
ventricular myocytes can be estimated by the levels of cAMP at
different experimental conditions. Figure 5D shows experimental
cAMP levels in ventricular myocytes from the rat and canine
hearts at the resting state after application of isoproterenol or
IBMX separately and at simultaneous application of IBMX and
isoproterenol. It is remarkable that the experimental data from
both species are very similar (bars with the errors in Fig. 5D). Our
model reproduces the experimental cAMP level after application
of different combinations of IBMX and isoproterenol (bars without
errors).
cAMP-PKA module. cAMP molecules generated in cardiac
myocytes by adenylyl cyclases and partially hydrolyzed by
phosphodiesterases activate protein kinase A, a major signaling
molecule in the b1-adrenergic signaling system which phosphorylates ion channels and proteins of the Ca2+ handling system.
Inactive PKA holoenzyme consists of two regulatory subunits R
(both either of type I, RI, or type II, RII) and two catalytic subunits
C. Activation of PKA holoenzyme requires binding four cAMP
molecules, in general, with different affinities. PKA holoenzyme
with bound four cAMP molecules dissociates two catalytic
subunits, which phosphorylates target proteins. In our model, we
consider identical affinities for all four binding sites of PKA. Two
isoforms of PKA holoenzyme are found in mouse ventricular
myocytes, PKAI and PKAII, which differ by their regulatory
subunits. PKAI is predominantly located in the cytosolic
compartment, and PKAII is the predominant isoform in the
caveolae and extracaveolae compartments.
PKAI and PKAII differ not only by their location, but also by
their half-activation constants, KPKAI and KPKAII. Some experimental data suggest half-activation constants for KPKAI , 0.1 mM
[50,51] and KPKAII , 0.5 mM [51], one of which is significantly
smaller and the other is comparable to the resting cAMP
concentrations in cardiac cells , 0.5–1 mM [52,53]. Under such
conditions, almost all PKA in the cytosol and most PKA in the
caveolae and extracaveolar compartments must be activated.
Other experimental data suggest KPKAI and KPKAII in the range ,
1.5–3 mM [54,55,56]. As it was pointed out by Dao et al. [55],
relatively small values of KPKAI and KPKAII in the nanomolar range
were obtained in some experiments because they used free
regulatory subunits RI or RII instead of PKA holoenzymes.
Experimental data with PKA holoenzymes yielded significantly
larger dissociation constants, which are used in our model (KPKAI,1
and KPKAI,2 = 2.9 mM [55]; KPKAII,1 and KPKAII,2 = 2.5 mM [8,54]).
Activation of PKA holoenzyme is described by ordinary differential equations (see Appendix S1). In addition, the model includes
inhibition of PKA by heat-stable protein kinase inhibitor (PKI), the
dynamics of which are also described by a differential equation.
Figure 6A shows activation levels of PKAI and PKAII as
functions of cAMP concentrations. We used experimental data
[54,55] shown by circles (PKAI) and squares (PKAII). Our
simulations are displayed by a solid (PKAI) and a dashed (PKAII)
line, respectively. They fit reasonably well to the experimental
data. We also simulated the cellular PKA activity ratio in control
and upon stimulation of the b1-adrenergic signaling system by
1 mM isoproterenol (Fig. 6B). Four simulations were performed for
this figure: no isoproterenol/basic cAMP level (2cAMP), no
isoproterenol/3 mM cAMP (+cAMP), 1 mM isoproterenol/no
externally applied cAMP (2cAMP), and 1 mM isoproterenol/
3 mM cAMP (+cAMP). Then, the corresponding PKA(2cAMP)/

Figure 4. Adenylyl cyclase activity as a function of isoproterenol. Panel A: Experimental data on AC activity (in pmol/mg/min) in
mouse hearts and ventricular myocytes obtained after 10-minutes
exposure to isoproterenol are shown by unfilled circles [42] and filled
circles [43]. The solid line shows corresponding simulated AC activities
at different concentrations of isoproterenol. Panel B: Desensitization of
b1-ARs. Increase in adenylyl cyclase activities above basal level (in %) are
measured at maximum (from 50th to 75th seconds, control, filled circles)
and at two time moments (5 min and 30 min, unfilled circles and
unfilled squares, respectively) after exposure to different concentrations
of isoproterenol [32]. Corresponding simulated data for the maximum,
5-minute, and 30-minute delays are shown by solid, dashed, and dashdotted lines, respectively.
doi:10.1371/journal.pone.0089113.g004

differences are diminished in Fig. 5B for fractional contributions of
different PDEs and between species. Our model successfully
reproduced both absolute PDE activities and the fractional
contributions of PDE2, PDE3, and PDE4 to the total cellular
PDE activity. In addition to the cellular activity, we were able to
PLOS ONE | www.plosone.org
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Figure 5. The effects of b1-adrenoceptor stimulation on PDE activities. Panel A: Absolute total PDE activities and the activities of PDE2,
PDE3, and PDE4 obtained experimentally from the mouse and rat hearts (in pmol/min/mg protein, bars with errors [44,49]) and corresponding
simulation data (bars without errors). Panel B: Fractional activities of PDE2, PDE3, and PDE4 obtained experimentally from the mouse and rat hearts
(in %, bars with errors [44,49]) and corresponding simulation data (bars without errors). Panel C: Partial activities of PDE2, PDE3, and PDE4 obtained
experimentally from the particulate fraction of the rat hearts (in %, bars with errors [48]) and corresponding simulation data (bars without errors). In
the experiments and simulations, PDE activities are obtained at fixed cAMP concentrations of 1 mM. Panel D: The effects of PDE inhibitor IBMX on
cAMP levels in ventricular myocytes. Experimental data for rat [147] and canine [148] ventricular myocytes are shown by bars with errors, simulation
data are shown by bars without errors. In the experiments with rat ventricular myocytes measurements were performed after 3-minute stimulations
(5 mM isoproterenol, or 100 mM IBMX, or both) [147]. In the experiments with canine ventricular myocytes measurements were performed after
5-minute stimulations (10 mM isoproterenol, or 10 mM IBMX, or both) [148]. Simulated cAMP level is determined at the 3rd minute upon application of
5 mM isoproterenol, or 100 mM IBMX, or both.
doi:10.1371/journal.pone.0089113.g005

the L-type Ca2+ channels and PP2A co-localize with caveolin-3,
suggesting caveolae localization for both PP1 and PP2A. PP1 and
PP2A are also localized in the cytosolic compartment, as they
interact with phospholamban and troponin I [59,60]. In mouse
hearts, PP1 is the predominant phosphatase, whose contribution to
the total phosphatase activity is ,75% [61,62]. As there is no
current consensus on whether PP1 or PP2A is predominant in the
extracaveolae compartment [63], we assume that only PP1
contributes to phosphatase activity in extracaveolae. We use
basically the same molar distribution of PP1 and PP2A in
subcellular compartments as Heijman et al. [8] (see Appendix S1),
provided that 75% and 25% of cellular phosphatase are of PP1
and PP2A, respectively, as found experimentally in mice [61,62].
In ventricular myocytes, protein phosphatase 1 is regulated
by endogenous inhibitor-1 (I-1) [64]. I-1 is localized in the
cytosolic compartment and inhibits PP1 activity when phosphorylated. Cellular concentration of I-1 is estimated as
½Inhib1cyt
tot = 0.08543 mM [65]. Ablation of I-1 leads to a moderate
increase in PP1 activity and impaired b1-adrenergic function
[64,65]. As the affinity of I-1 to PP1 is very high (KInhib1 = 1 nM),

PKA(+cAMP) ratios were calculated. The simulations (grey bars)
compare well to the experimental data for the rabbit hearts
obtained in control and after application of 1 mM isoproterenol
(black bars [57]).
The effect of a heat-stable protein kinase inhibitor (PKI) on the
PKA activity is shown in Fig. 6C. Experimental data obtained
from [54] for PKA II are shown by filled circles, and simulation
results are plotted by a solid line for PKA I and by a dashed line
for PKA II. PKA activities are calculated with and without PKI at
different concentrations of cAMP, then their ratios were calculated
(in %) and subtracted from 100%. As seen from Fig. 6C, model
simulations fit reasonably well to the experimental data.
Protein phosphatases and inhibitor-1 module. There are
two major types of protein phosphatases which are important for
cardiac myocyte function, protein phosphatase 1 (PP1) and 2A
(PP2A). Localization of PP1 and PP2A in three subcellular
compartments can be determined by their co-localization with
caveolin-3 and by modulation of their targets. Data of Hescheler
et al. [58] and Balijepalli et al. [19] show that the L-type Ca2+
current is inhibited by both PP1 and PP2A, and that the portion of
PLOS ONE | www.plosone.org
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and subtracted from 100% (filled circles, [54]). Corresponding simulation data for PKA I and PKA II are shown by solid and dashed lines.
Concentration of [PKI]tot = 2?0.2?[PKA]tot.
doi:10.1371/journal.pone.0089113.g006

we used steady-state approximation to describe I-1-PP1 interaction with corresponding mass conservation relationships:

cyt
½Inhib1cyt
p,tot ~½Inhib1p z

cyt
½PP1cyt
tot ~½PP1f z

cyt
:
½PP1cyt
f ½Inhib1p

KInhib1

cyt
:
½PP1cyt
f ½Inhib1p

KInhib1

cyt
cyt
½Inhib1cyt
tot ~½Inhib1f z½Inhib1p,tot :

:

:

ð3Þ

ð4Þ

ð5Þ

where ½Inhib1cyt
p,tot is the total concentration of phosphorylated I-1
in cytosol, ½Inhib1cyt
is the unbound phosphorylated I-1
p
is the non-phosphorylated I-1 conconcentration, ½Inhib1cyt
f
is
the
total
concentration of PP1 in cytosol, and
centration,½PP1cyt
tot
is
the
unbound
PP1
concentration.
Solution of equations
½PP1cyt
f
(3) – (5) gives the equations for calculating ½Inhib1cyt
f ,
cyt
(see equations (A.124) – (A.129) in the
½Inhib1cyt
p , and ½PP1f
Appendix S1). Phosphorylation and dephosphorylation of I-1
occurs by the catalytic subunit of PKA and PP2A, respectively
[64,66], and is described by equation (A.130) (see Appendix S1).
Figure 7A shows the effects of activation of the b1-adrenergic
signaling system by 1 mM isoproterenol on inhibitor-1 activity. As
there is no data for mice, we used the experimental data from
guinea pig hearts [67] which shows significant activation of I-1
from ,20% to ,80% of its maximum activity. Our model
reproduced the experimental data on I-1 activation. The effects of
I-1 on PP1 activity can be estimated from data obtained from WT
and I-1 knockout mice [64]. Figure 7B shows a slight increase in
PP1 activity upon I-1 ablation (activity of PP1 in I-1 knockout
mice is normalized to 100%). In the model, the effect of I-1
knockout is simulated by setting ½Inhib1cyt
tot = 0, which leads to a
slightly smaller increase in PP1 activity compared to that found
experimentally.
cAMP dynamics. cAMP is a one of the major signaling small
molecules in the b1-adrenergic signaling system. It moves freely
between cellular compartments and has PKA as a major target.
cAMP concentration is determined by the balance between cAMP
production by adenylyl cyclases, cAMP degradation by phosphodiesterases, and cAMP diffusion between intracellular compartments (caveolae, extracaveolae, and cytosol) (see (A.131)-(A.133) in
Appendix S1). Experimental data with unstimulated cells shows
cAMP concentrations in mouse ventricular myocytes in the range
from 2.4 to 6.0 pmol/mg protein (0.4522–1.13 mM) [43,52,53].
Our model gives a background cellular cAMP concentration
, 0.3 mM. This concentration is close to the experimental values
and to the values obtained in the models of others [8,11].
Stimulation of the b1-adrenergic signaling system results in an
increase of cAMP production by adenylyl cyclases and cAMP
degradation by phosphodiesterases in the caveolae, extracaveolae,
and cytosolic compartments. Figure 8A shows experimental time
courses of normalized cAMP in mouse [68] and rabbit [57]
ventricular myocytes obtained upon stimulation with 1 mM
isoproterenol (unfilled and filled circles, respectively). A solid line

Figure 6. The effects of b1-adrenoceptor stimulation on PKA
activities. Panel A: PKA I and PKA II activities as functions of cAMP.
Experimental data for PKA I obtained by two methods are shown by
filled and unfilled circles [55]; data for PKA II obtained by Beavo et al.
[54]. Corresponding simulated data are shown by a solid (PKA I) and a
dashed (PKA II) line. Panel B: PKA activity ratio. Experimental data were
obtained without (2cAMP) and with (+cAMP) externally applied 3 mM
cAMP, both without and with 1 mM isoproterenol (black bars [57]). We
also performed four simulations: no isoproterenol/basic level cAMP
(2cAMP), no isoproterenol/3 mM cAMP (+cAMP), 1 mM isoproterenol/no
externally applied cAMP (2cAMP), and 1 mM isoproterenol/3 mM cAMP
(+cAMP). Then, the corresponding PKA ratios were calculated. Panel C:
Protein kinase A inhibition by a heat-stable protein kinase inhibitor PKI.
Experimentally, PKA activities were measured with and without PKI at
different concentrations of cAMP, then their ratio was calculated (in %)
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Figure 7. The effects of b1-adrenoceptor stimulation on
activities of I-1 and PP1. Panel A: Relative I-1 activity in ventricular
myocytes in control (left bars) and upon stimulation with 1 mM
isoproterenol (right bars). Experimental data for guinea pig hearts
[67] are shown by black bars, simulation data with our model are shown
by gray bars. Panel B: Relative PP1 activity in WT and I-1 knockout
mouse hearts. Experimental data [64] are shown by black bars, our
simulations – by gray bars. Experimental PP1 activity from I-1 knockout
mouse hearts is normalized to 100%.
doi:10.1371/journal.pone.0089113.g007

Figure 8. cAMP and PKA dynamics in mouse ventricular
myocytes. Panel A: cAMP dynamics in ventricular myocytes.
Experimental data of normalized cAMP in mouse [68] and rabbit [57]
ventricular myocytes are shown by unfilled and filled circles,
respectively; simulation data is shown by a solid line. Panel B: PKA
dynamics in ventricular myocytes. Experimental data of normalized PKA
activity in rabbit [57] ventricular myocytes are shown by unfilled circles;
simulation data is shown by a solid line. Data in Panels A and B was
obtained upon application of 1 mM isoproterenol.
doi:10.1371/journal.pone.0089113.g008

Model Development: Electrophysiological Part

in Fig. 8A shows corresponding simulated time behavior of cAMP.
Both simulated and experimental data show transient increase in
cAMP concentration, which is due to changes in cAMP
production by adenylyl cyclases, cAMP degradation by phosphodiesterases, cAMP fluxes between compartments, and b1-ARs
desensitization.
PKA dynamics. Our model is able to reproduce the time
course of the cellular PKA activity, which is determined by the
cellular concentration of catalytic subunit (solid line in Fig. 8B). As
there is no data for mice, we used data of Buxton and Brunton
[57] (unfilled circles in Fig. 8B) obtained for rabbit ventricular
myocytes to constrain the model. Similar to cAMP dynamics,
both experimental and simulation data for PKA demonstrate
transient increase in activation, with subsequent decrease in
activity.

PLOS ONE | www.plosone.org

Electrical activity of the mouse ventricular myocytes is described
by the equation for transmembrane potential [25]:
dV
1
(ICaL zIp(Ca) zINaCa zICab zINa zINab zINaK
~{
dt
Cm
zIKto,f zIK1 zIKur zIKss zIKr zICl,Ca {Istim ):
where ICaL is the L-type Ca2+ current, Ip(Ca) is the sarcolemmal
Ca2+ pump, INaCa is the Na+/Ca2+ exchanger, ICab is the Ca2+
background current, INa is the fast Na+ current, INab is the Na+
background current, INaK is the Na+-K+ pump, IKto,f is the rapidly
recovering transient outward K+ current, IK1 is the timeindependent K+ current, IKur is the ultrarapidly activating delayed
rectifier K+ current, IKss is the noninactivating steady-state voltage
activated K+ current, IKr is the rapid delayed rectifier K+ current,
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ICl,Ca is the Ca2+-activated chloride current, and Istim is the
stimulus current.
In our model, we consider four of these currents (ICaL, INa,
IKto,f, and IKur) as the substrates of the b1-adrenergic signaling
system. The Na+/K+ pump is affected by b1-ARs through
phosphorylation of phospholemman. One more current, IK1, is
also affected by b1-ARs; however, in the voltage range from about
280 to +40 mV, this current does not change significantly. In
addition, there are three other phosphorylation substrates, which
are the major players in Ca2+ dynamics and are affected by
b1-ARs: ryanodine receptors, phospholamban, and troponin I. We
consider all these b1-adrenoceptor substrates below as separate
modules in the model.
L-type Ca2+ current module. As found experimentally,
the L-type Ca2+ channels are localized in both the caveolae and
the extracaveolae compartments [19,21,22,69]. About 80% of the
L-type Ca2+ channels are found within Ca2+ release units, or
couplons [21], which are localized in the extracaveolae compartment, contribute directly to excitation-contraction coupling, and
are the targets of the b1-adrenergic signaling system [22,70]. The
other 20% of the L-type Ca2+ channels are found in the caveolae
[19,22]. The total amount of L-type Ca2+ channel protein can be
estimated from the experimental data on the amount of RyRs in
the mouse hearts (1058645 fmol/mg protein, or 0.1993 mM [71])
and dihydropyridine (DHPR) receptor-to-RyRs ratio for rats
(RyR/DHPR = 7.3 [72]), resulting in [ICaL]tot = 0.0273 mM. In
the presented model, 20% and 80% of the L-type Ca2+ channels
are localized in the caveolae and the extracaveolae compartments,
respectively.
Effects of the b1-adrenergic signaling system on the L-type Ca2+
channels and channel gating can be described with a Markov
model for non-phosphorylated and phosphorylated states (Fig. 9A).
The model includes two activation pathways: one for nonphosphorylated and one for phosphorylated channels. Each
pathway includes five closed, one open, and three inactivated
states. Transitions between non-phosphorylated and phosphorylated states are determined by the rates of phosphorylation by
PKA and dephosphorylation by PP1 and PP2A (see Appendix S1).
As we were unable to reproduce the experimental data on
isoproterenol effects on the L-type Ca2+ channels with the Markov
model from [25,26] due to the high maximum opening probability
for the channels at large depolarizations, we introduced a voltageindependent rate limiting step and a new closed state (CP, closed
pre-open state) in the new model (Fig. 9A), which reduced the
opening probability for non-phosphorylated channels compared to
the models of Bondarenko et al. [25] and Petkova-Kirova et al.
[26]. Experimental data shows that the stimulation of b1-ARs
increases the magnitude of the L-type Ca2+ current and causes a
hyperpolarization shift in normalized channel conductance (G/
Gmax) and a steady-state inactivation relationship in mouse
ventricular myocytes [73,74,75]. These effects are simulated by
several changes to the phosphorylated pathway in the model (see
Appendix S1) and an increase in GCaLp (GCaLp = 2.09GCaL
according to the estimation of an increase in maximum opening
probability for cardiac Ca2+ channels from [76]).
Model parameters are adjusted to fit experimental data on both
the basal L-type channel phosphorylation level and the time
course of the current amplitude upon stimulation with isoproterenol. Experimental data suggest the basal phosphorylation level of
the L-type Ca2+ channels in ventricular myocytes to be about
13–20% [77,78]. In our model, a fraction of phosphorylated
channels under basal conditions is set to 10.3%. Upon application
of 1 mM isoproterenol, peak values of ICaL increase in time upon
stimulation with voltage pulses to 0 mV, as is seen from the
PLOS ONE | www.plosone.org

experimental data [75] (Fig. 9B). Our model reproduced the time
course of the peak current increase under similar stimulations
(solid line in Fig. 9B). It is remarkable that the simulated time
course of the peak current increase (solid line in Fig. 9B) is very
similar to the simulated time course of the relative phosphorylation
level of the L-type Ca2+ channels (dashed line in Fig. 9B).
In addition to the time course of ICaL increase, we simulated
magnitudes of ICaL increase after a 600-second exposure to
different concentrations of isoproterenol (Fig. 9C). We evaluated
the effects of isoproterenol on the total ICaL (ICaL,tot, black bold
solid line in Fig. 9C) as well as on ICaL populations localized in the
caveolae (ICaL,cav, green line in Fig. 9C) and extracaveolae
(ICaL,ecav, red line in Fig. 9C) compartments. The results of
simulations for the total ICaL are in a good agreement with the
experimental data obtained by Kim et al. [79], Sako et al. [80],
and Mitarai et al. [81] (Fig. 9C). Simulations also show that the
effects of b1-adrenergic receptor agonist is significantly stronger on
the channels localized in the extracaveolae compartment (2.03
folds at 1 mM Iso) compared to the channels in the caveolae
compartment (1.42 folds at 1 mM Iso). If the caveolae-located ICaL
is responsible for ,20% of the total current amplitude in control,
after exposure to isoproterenol (1 mM) this fraction decreases to
,15%. The results of simulations are in line with the experimental
data of [70] who have shown that the ICaL from the population of
channels in the caveolae compartment comprises about 15% of
the total current.
In addition to the effects of activation of the b1-adrenergic
signaling system, our model is tested in respect to the effects of
inhibition of phosphatase activity on the L-type Ca2+ current.
Figure 9D shows simulated ICaL traces under heavy buffer
conditions (with suppression of Ca2+-induced Ca2+ release) elicited
by voltage pulses to 0 mV in control (solid line) and after 1000-s
exposure to 1 mM Calyculin A (dashed line) and 600-s exposure to
1 mM isoproterenol (dotted line). In simulations, we consider that
Calyculin A inhibits 65% of the activity of both PP1 and PP2A. As
seen from simulations in Fig. 9D, both isoproterenol and Calyculin
A increase peak currents to different degrees, suggesting that both
activation of PKA and inhibition of PP1 and PP2A increase the
L-type Ca2+ current. Fitting simulated time courses from Fig. 9D
yields bi-exponential inactivation of ICaL with two time constants.
Fast (Ca2+-dependent inactivation) and slow (voltage-dependent
inactivation) time constants are equal to 7.77 and 22.0 ms, 7.19
and 19.9 ms, and 6.54 and 18.5 ms for control (solid line), after
1000-s exposure to 1 mM Calyculin A (dashed line), and 600-s
exposure to 1 mM isoproterenol (dotted line), respectively. These
data show significant increase in Ca2+-dependent inactivation of
ICaL upon stimulation of the b1-adrenergic signaling system.
Similar behavior of ICaL is also observed experimentally with
BAPTA in pipette solution [73]. Insert in Fig. 9D shows similar
simulations with intact Ca2+-induced Ca2+ release. In the last case,
current traces also show bi-exponential decay with the fast and
slow time constants 4.83 and 12.4 ms, 4.72 and 12.0 ms, and 4.66
and 12.8 ms for control (solid line), after 1000-s exposure to 1 mM
Calyculin A (dashed line), and 600-s exposure to 1 mM isoproterenol (dotted line), respectively. These data show significant
increase in the L-type Ca2+ current inactivation with intact Ca2+
dynamics. Simulations also show that activation of b1-ARs
increases peak current amplitudes by about two-fold (Fig. 9E)
and causes a hyperpolarization shift in steady-state inactivation
relationships (Fig. 9F) and more moderately in G/Gmax data
(Fig. 9G). Inhibition of PP1 and PP2A produced an intermediate
effect on the ICaL in terms of an increase in amplitude and
a hyperpolarization shift of steady-state inactivation relationships and G/Gmax. Similar increases in amplitudes and
10
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Figure 9. The effects of b1-adrenoceptor stimulation on the L-type Ca2+ current. Panel A: Markov model of the L-type Ca2+ channel. State
diagram consists of two similar sub-diagrams for non-phosphorylated (upper sub-diagram) and phosphorylated states (lower sub-diagram). C1, C2, C3,
C4, and CP are closed states; O is the open state; I1, I2, and I3 are inactivated states; C1p, C2p, C3p, C4p, and CPp are closed phosphorylated states; Op is
the open phosphorylated state; and I1p, I2p, and I3p are phosphorylated inactivated states. The rate constants a, ap, and b are voltage-dependent; c is
calcium dependent; kco, koc, kcop, Kpcf and Kpcb, are voltage-insensitive; and kphos and kdephos are the phosphorylation and dephosphorylation rates,
respectively (see Appendix S1). Panel B: Time course of the peak values of L-type Ca2+ current and L-type Ca2+ channel phosphorylation level upon
stimulation with 1 mM isoproterenol. Experimental data for peak ICaL is obtained by a series of pulses to 0 mV for 200 ms from a holding potential of
280 mV with a frequency 0.2 Hz [75]. Modeling data are obtained by a series of pulses to 0 mV for 50 ms from a holding potential of 280 mV with a
frequency 0.04 Hz. Increase in phosphorylation level is determined as a fractional increase related to the total increase in phosphorylation of L-type
Ca2+ channels at 150th s after application of isoproterenol. Panel C: Peak L-type Ca2+ current as a function of isoproterenol concentration.
Experimental data are obtained by Kim et al. [79] (filled circles), Sako et al. [80] (unfilled circles), and Mitarai et al. [81] (filled squares). Simulation data
is obtained by a voltage pulse to 0 mV from a holding potential of 280 mV after a 600-second exposure to different concentrations of isoproterenol.
Simulation data for the total cellular ICaL,tot, the caveolae-localized ICaL,cav, and the extracaveolae-localized ICaL,ecav are shown by black, green, and red
solid lines, respectively. Panel D: Simulated time course of the L-type Ca2+ currents in control (solid line), after 1000-s exposure to PP1/PP2A inhibitor
Calyculin A (65% of PP1/PP2A activity inhibition, dashed line), and after 600-s exposure to 1 mM isoproterenol (dotted line). Currents are obtained by
a voltage pulses to 0 mV from a holding potential of 280 mV and without Ca2+-induced Ca2+ release to account for heavy buffer conditions. Insert in
Panel D: Same simulations performed with intact Ca2+-induced Ca2+ release. Panel E: Peak current-voltage (I–V) relationships for ICaL in control
(filled circles) and after exposure to Calyculin A (unfilled circles) and isoproterenol (filled squares). Panel F: Steady-state inactivation relationships for
ICaL in control (filled circles) and after exposure to Calyculin A (unfilled circles) and isoproterenol (filled squares). Panel G: Normalized maximum
conductance (G/Gmax) for ICaL as functions of voltage in control (filled circles) and after exposure to Calyculin A (unfilled circles) and isoproterenol
(filled squares). In Panels E, F, and G, currents are obtained by the two-pulse protocols: a 500-ms depolarizing first pulse to between 270 and
+50 mV (in 10-mV increment) is applied from a holding potential of 280 mV; this is followed by a second 500-ms pulse to +10 mV. Simulations are
performed without Ca2+-induced Ca2+ release to account for heavy buffer conditions.
doi:10.1371/journal.pone.0089113.g009

one rate constant to characterize the effect of PKA, kphos,tr, which
includes both channel’s phosphorylation and trafficking. Two
activation pathways are used, one is for non-phosphorylated
channels and another is for phosphorylated-trafficked channels
(Fig. 10A). Because isoproterenol does not change the gating
properties of INa, we use the same rate constants for both nonphosphorylated and phosphorylated-trafficked channels. The
larger conductance is used for the phosphorylated-trafficked
channels (see the fast Na+ current module in Appendix S1). We
consider that the fast Na+ channels are dephosphorylated by PP1
and PP2A (Fig. 10A, Appendix S1). The set of equations that
describes the fast Na+ channel gating is provided in Appendix S1
((A.180) - (A.213)).
The resulting model for the fast Na+ current was tested against
the experimental data on the time course of INa activation, its
dependence on the isoproterenol concentration, and voltageclamp experiments (Fig. 10). As there is no data for mice, we used
the experimental time course of the activation of INa by 0.1 mM
isoproterenol obtained from rabbit ventricular myocytes (filled
circles in Fig. 10B). Figure 10B shows a good agreement between
the experimental and simulated time dependences of INa
amplitude upon stimulation of the b1-adrenergic signaling system.
A similar time course is demonstrated by the simulated fraction of
phosphorylated and trafficked Na+ channels (solid line in Fig. 10B).
The model also successfully reproduced the concentration
dependence of an increase in Na+ channel availability at different
concentrations of isoproterenol (Fig. 10C).
Experimental data shows an increase in the fast Na+ current
amplitude upon stimulation with 0.1 mM isoproterenol (Fig. 10D,
unfilled and filled circles). A similar increase is obtained from our
Markov model for Na+ channels (solid and dashed lines in Fig. 10D
are for control and 0.1 mM isoproterenol, respectively). Neither
the experimental data (unfilled and filled circles in Fig. 10E) nor
the simulations (solid and dashed lines in Fig. 10E) demonstrate
significant changes in steady-state inactivation relationships.
Ryanodine receptor module. Experimental studies of
ryanodine receptors in rat ventricular myocytes provided evidence
of their co-localization in couplons with the L-type Ca2+ channels
(in dyads, or subspace volume Vss) or in close proximity to those
couplons [21,22,91]. Between 80 to 85% of ryanodine receptors
are localized in Vss and the rest are very close to dyads, which
suggests their involvement in Ca2+-induced Ca2+ release [21,91].

hyperpolarization shifts are also observed experimentally [73].
Therefore, our model for the b1-adrenergic signaling system is able
to simulate the effects of both activation of PKA and inhibition of
PP1 and PP2A on the L-type Ca2+ current, ICaL.
Fast Na+ current module. The channels responsible for the
fast Na+ current, INa, which are encoded by Nav1.5 subunit, are
found in the caveolae compartment [16,69,82]. Using both
immunoblot analysis and imaging technique, Yarbrough et al.
[82] provided evidence of co-localization of the fast Na+ channels
and caveonin-3 in rat cardiomyocytes, suggesting their localization
in the caveolae compartment. Similar data were also obtained by
Shibata et al. [69] by using immunogold labeling of plasma
membranes from rat cardiomyocytes, where Nav1.5 subunits were
co-localized on electron microscope images with caveolin-3. In
addition, Palygin et al. [83] provided evidence of the involvement
of caveolin-3 in isoproterenol-induced enhancement of INa in
ventricular myocytes.
Activation of the b1-adrenergic signaling system with isoproterenol leads to an increase in the amplitude of INa, however, without
the effects on gating properties of the channel [84,85]. Simultaneous activation of several components of the b1-adrenergic
signaling system with cAMP-IBMX-forskolin cocktail or with
excessive application of membrane permeant analogue of cAMP,
CPTcAMP (5 mM), results in additional small shift in the G/Gmax
and steady-state inactivation [86,87,88]. Experimental data of
Baba et al. [86] also shows that the inhibition of protein
phosphatase PP2A causes an increase in INa, and the addition of
PP2A to pipette solution causes a decrease in INa, which link
phosphorylation level of INa to its magnitude. Mechanism of the
changes in INa was studied by Zhou et al. [88] in detail. It was
shown that, in addition to channel phosphorylation, an increased
number of functional fast Na+ channels in the cell membrane is
due to the channel trafficking. More recent analysis of the effects of
PKA on INa suggested that phosphorylation and trafficking of INa
are related processes: channels’ phosphorylation increases trafficking of fast Na+ channels [89].
To simulate these effects, we developed a Markov model for INa,
based on the model [25,90], in a similar way as for ICaL, but with
some differences. We consider that the amplification of INa occurs
through two processes: phosphorylation of the channels and their
subsequent trafficking to the cell membrane. As the kinetics of the
two processes are indistinguishable in the experiments, we use only
PLOS ONE | www.plosone.org
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Figure 10. The effects of b1-adrenoceptor stimulation on the fast Na+ current. Panel A: Markov model of the fast Na+ channel. State
diagram consists of two similar sub-diagrams for non-phosphorylated (upper sub-diagram) and phosphorylated-trafficked states (lower sub-diagram).
CNa1, CNa2, and CNa3 are closed states; ONa is the open state; IFNa, I1Na, and I2Na are the fast, intermediate, and slow inactivated states, respectively;
ICNa2 and ICNa3 are closed-inactivated states; CNa1p, CNa2p, and CNa3p are closed phosphorylated states; ONap is the open phosphorylated state; and
IFNap, I1Nap, I2Nap, ICNa2p, and ICNa3p are phosphorylated inactivated states. The rate constants for activation, deactivation, inactivation,
phosphorylation-trafficking, and dephosphorylation are given in Appendix S1. Panel B: Time course of the activation of the fast Na+ current upon
application 0.1 mM isoproterenol. Experimental data of Matsuda et al. [85] obtained for the normalized peak INa in rabbit ventricular myocytes is
shown by closed circles. Data is obtained with 40-ms pulses from a holding potential of 2100 mV to 230 mV at stimulation frequency 0.2 Hz. A solid
line shows the time course of simulated data on relative INa phosphorylation upon application of 0.1 mM isoproterenol. A dashed line shows the time
course of the simulated normalized peak INa after application of 0.1 mM isoproterenol. The simulated currents are obtained with 20-ms pulses from a
holding potential of 2140 mV to 230 mV at stimulation frequency 0.04 Hz. Panel C: An increase in peak INa availability upon application of different
concentrations of isoproterenol (in %). Experimental data by Kirstein et al. [84] obtained from rat ventricular myocytes are shown by black bars with
errors; corresponding simulation data are shown by gray bars. Peak current-voltage (Panel D) and steady-state inactivation (Panel E) relationships
for the fast Na+ current in ventricular myocytes upon stimulation with 0.1 mM isoproterenol. Experimental data for rats in the absence (unfilled circles)
and presence (filled circles) of 0.1 mM isoproterenol are obtained by Kirstein et al. [84] (holding potential is 2100 mV, conditioning pulse duration is
2,500 ms; isoproterenol data is obtained after 10 min of application). Simulated data are shown by solid (no isoproterenol) and dashed (10 min after
application of 0.1 mM isoproterenol) lines (data are obtained by two-pulse protocol, holding potential is 2140 mV, first pulse duration is 500 ms for
voltages from 2140 to +40 mV in 10 mV steps, second pulse duration is 50 ms at voltage 220 mV). Isoproterenol increases INa availability, but does
not affect gating properties.
doi:10.1371/journal.pone.0089113.g010

However, such data were obtained at relatively small luminal Ca2+
concentrations (45 nM), which increased sensitivity of RyRs by an
order of magnitude compared to normal physiological conditions
(compare the data shown by filled and unfilled circles (small
luminal Ca2+ concentrations) with the data shown by filled squares
(normal physiological luminal Ca2+ [96])). To estimate the effects
of PKA on RyRs, we simulated two dependences of RyRs opening
probabilities on cytosolic Ca2+: the first is obtained by stimulation
of the cell with intact PKA (solid line in Fig. 11D), the second is
obtained by setting [PKA]tot = 0 mM. Our model shows a
reasonable agreement of the Ca2+-dependence of the RyRs
opening probability with the experimental data [96], but virtually
no change in the sensitivity of phosphorylated RyRs to cytosolic
Ca2+ concentration. Some deviations between the experimental
(filled squares) and simulated (solid line) data at relatively large
cytosolic Ca2+ concentrations can be due to the method of
estimation of the opening probabilities: in the simulations, we used
the maximum values of the channel’s opening probabilities,
without consideration of the effects of ryanodine receptor
inactivation, while in the single-channel experiments, such
inactivation is always present and can potentially reduce measured
opening probability.

Very small portions (,3.5–9.2%) of ryanodine receptors in mouse
ventricular myocytes are shown to co-localize with caveolin-3, but
outside of couplons, but their functional significance is unclear
[35,92]. Therefore, in the model, we put ryanodine receptors in
the extracaveolae compartment. The receptors are subjects of
phosphorylation by PKA and dephosphorylation by PP1. The
total concentration of RyRs in mouse ventricular myocytes was
determined experimentally by Chu et al. [71] and is equal to
0.1993 mM.
A Markov model for ryanodine receptor gating, which includes
phosphorylation-dephosphorylation processes, is shown in
Fig. 11A. As for two other substrates, ICaL and INa, we developed
a Markov model that consists of two populations of the channels,
non-phosphorylated and phosphorylated. For non-phosphorylated
channels, we employed our previously developed Markov model
for RyRs, which contains two closed (C1 and C2) and two open
(O1 and O2) states [25]. We added two closed-phosphorylated (C1p
and C2p) and two open phosphorylated (O1p and O2p) states to the
model and the transitions between corresponding non-phosphorylated and phosphorylated states (Fig. 11A). Because experimental
data suggest slightly increased sensitivity of RyRs to cytosolic Ca2+
concentration [93], we sped up the forward transition rates to a
greater magnitude than the backward transition rates for the
phosphorylated channels (see Appendix S1). Differential equations, which describe the time behavior of the RyRs’ probabilities
in closed and open states, are shown in Appendix S1 (Eqs. (A.214)(A.222)).
Our model successfully reproduced the time course of
the ryanodine receptor phosphorylation upon stimulation of
b1-adrenoceptors. Figure 11B shows experimental time behavior
of the relative phosphorylation level of RyRs in rat ventricular
myocytes during exposure to 1 mM isoproterenol [94]. A similar
time course is demonstrated by our model (solid line in Fig. 11B)
and by the experimental data which used a different technique of
RyR phosphorylation (by endogenous PKA in canine ventricular
myocytes upon application of [c-32P]ATP [95]). Figure 11C (filled
circles) shows experimental data on the phosphorylation level of
RyRs at different concentrations of isoproterenol [94]. Our model
is able to reproduce this dependence as well (solid line in Fig. 11C).
In addition, the model simulated dependence of the RyRs open
probability as a function of intracellular Ca2+ concentration for
non-phosphorylated and phosphorylated channels (Fig. 11D). The
experimental data on the effects of PKA on RyRs shows a tiny
shift of the dependence of phosphorylated RyRs’ opening
probability towards a smaller cytosolic Ca2+ concentration [93].
PLOS ONE | www.plosone.org

Phospholemman
and
the
Na+-K+
pump
module. Experimental data on the localization of the Na+-K+

pump shows that ,30–40% of a1-subunits and 80–90% of
b1-subunits are localized in the caveolae-rich membrane fractions
[97]. Another study provided similar data on the Na+-K+ pump
and caveolin-3 co-localization, where ,70% of those proteins are
found in the same fractions [98]. Moreover, almost all the Na+-K+
pump activity was found in caveolae [97,99].
In our model, the phospholemman, which regulates the Na+-K+
pump, is the third substrate of the b1-adrenergic signaling system
located in the caveolae compartment. Activation of b1-ARs
increases the function of the Na+-K+ pump by phosphorylation
of phospholemman (PLM) through the effective change in
dissociation constant Km,Nai [12], thereby decreasing intracellular
[Na+]i concentration [100]. An experimental time course of a
relative decrease in [Na+]i in mouse ventricular myocytes after
application of 1 mM isoproterenol is shown in Fig. 12A by filled
circles. A corresponding simulated time course of a relative PLM
phosphorylation level is shown by a solid line. An increase in the
phosphorylation level of PLM decreases the Na+ half-saturation
constant for the current and effectively increases the pumping rate
of Na+ outside the cell. Both time dependences demonstrate
similar behavior.
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Figure 11. The effects of b1-adrenoceptor stimulation on ryanodine receptors. Panel A: Markov model of ryanodine receptors. State
diagram consists of two similar sub-diagrams for non-phosphorylated (upper sub-diagram) and phosphorylated states (lower sub-diagram). C1 and C2
are closed states; O1 and O2 are open states; C1p and C2p are closed phosphorylated states; O1p and O2p are open phosphorylated states. The rate
constants from C1 to O1, from O1 to O2, from C1p to O1p, and from O1p to O2p are Ca2+-dependent; and kphos and kdeph are the phosphorylation and
dephosphorylation rates, respectively (see Appendix S1). Panel B: Time course of the relative phosphorylation level of RyRs upon activation of the
b1-adrenergic signaling system. Experimental data of Xiao et al. [94] (filled circles) are obtained upon stimulation of rat ventricular myocytes with
1 mM isoproterenol; experimental data of Takasago et al. [95] (filled squares) are obtained from canine ventricular myocytes with endogenous PKA by
application of [c-32P]ATP. Modeling data are obtained by application of 1 mM isoproterenol. Increase in phosphorylation level is determined as a
fractional increase related to the maximum increase in phosphorylation of RyRs after activation of the b1-adrenergic signaling system. Panel C:
Relative phosphorylation level of RyRs at different concentrations of isoproterenol. Experimental data of Xiao et al. [94] (filled circles) obtained upon
stimulation of rat ventricular myocytes for 15 minutes. Simulation data are obtained after 10-minute exposure to different concentrations of
isoproterenol. Panel D: Effects of PKA on opening probability of RyRs as function of cytosolic Ca2+ concentration. Experimental data of Xiao et al.
[93] are obtained for cardiac RyRs upon application of active (filled circles) and boiled (unfilled circles) PKA at relatively small luminal Ca2+ of 45 nM;
experimental data of Xiao et al. [96] (filled squares) for RyRs are obtained from mouse ventricular myocytes. Simulation data for mouse ventricular
myocytes in the absence and presence of PKA are obtained at intracellular [Ca2+]i concentration ranged from 0.01 to 10 mM and are shown by dashed
and solid lines. Experimental data obtained at small luminal Ca2+ concentration shows larger sensitivity of RyRs to cytosolic Ca2+.
doi:10.1371/journal.pone.0089113.g011

compartment in our model is the rapidly recovering transient
outward K+ current, IKto,f. IKto,f is found in lipid rafts that lack
caveolin-3 pointing to non-caveolae localization [15,69,105].
Heijman et al. [8] also placed Ito1, which is encoded by Shaltype K+ channels (Kv4.2/Kv4.3), to the extracaveolae compartment.
There are only a few qualitative experimental data on the effects
of activation of the b1-adrenergic signaling system on IKto,f in
cardiac cells [109]. Experimental data of Gonzalez de la Fuente
et al. [109] shows clear inhibition of Ito1 by isoproterenol (0.1 mM)
in human left and right atrial myocytes by about 40–50%. Similar
inhibition is obtained in neural cells [110] for A-type K+ current,
IA, which is also encoded by Shal-type K+ channels (Kv4.2), after
application of 8-br-cAMP (100 mM), and Schwann cells [111] after
application of bradykinin (5 mM), forskolin (1 mM), or db-cAMP
(10 mM). Our simulation data shows about a two-fold decrease in
peak IKto,f at saturating concentrations of isoproterenol (Fig. 13E).
Figure 13D shows experimental time courses of IA-current
inhibition by forskolin (1 mM) or db-cAMP (10 mM) obtained in
Schwann cells [111] (filled and unfilled circles, respectively). Our
simulation, shown by a solid line for the saturating concentration
of isoproterenol (10 mM), gives a reasonable agreement with the
experimental data. The saturating concentration of isoproterenol
was chosen in the simulation to obtain cAMP concentration in the
extracaveolae compartment similar to the experimental values and
maximum activation of PKA.
Simulated time courses of IKto,f in control and after application
of 10 mM isoproterenol are shown in Fig. 13E by solid and dashed
lines, respectively. Calculations demonstrate about a two-fold
inhibition of peak current after stimulation of b1-ARs. A similar
level of inhibition of IA is obtained by activation of PKA with
saturating concentrations of 8-br-cAMP (100 mM) in neural cells
[110], and Ito1 after application of saturating concentrations of
isoproterenol in human left and right atrial cells [109]. Simulations
also demonstrate depolarization shifts in voltage dependences of
G/Gmax (13 mV) and steady-state inactivation (6 mV) for
isoproterenol-stimulated compared to control cells (Fig. 13F),
which is similar to the experimental data from [110] obtained for
neural cells.
Time-independent K+ current module. While experimental data shows the effects of activation of the b1-adrenergic
signaling system on the time-independent current IK1, such effects
are clear only at potentials below 280 mV [112,113]. Therefore,
we did not include modulation of IK1 by b1-ARs in our model.
Phospholamban module. Phospholamban is the first PKA
substrate in the cytosolic compartment, which is included in our
model [114]. Its major role is the regulation of SERCA pump
activity by changing the affinity of the latter. Activation of the

Figure 12B shows the experimental dependence of the relative
increase in INaK as a function of isoproterenol concentration
obtained from guinea pig ventricular myocytes (filled circles [101]).
We compared the experimental data to our simulations of a
relative increase in the phosphorylation level for phospholemman
(solid line in Fig. 12B). In general, simulation data has a
dependence on isoproterenol concentration similar to the experimental data, except for a point at 0.01 mM isoproterenol. Such
deviation could be due to the species differences.
Finally, our model successfully reproduced the experimental
behavior of intracellular [Na+]i concentration in mouse ventricular
myocytes measured before and 10 minutes after an application of
1 mM isoproterenol (Fig. 12C, [100]). Both the experimental and
simulation data show relatively small, but significant decreases in
[Na+]i after stimulation of the b1-adrenergic signaling system.
Ultra-rapidly activating delayed rectifier K+ current
module. The ultra-rapidly activating delayed rectifier K+

current, IKur, is the substrate of PKA in the extracaveolae
compartment in cardiomyocytes [15,102]. IKur is predominantly
encoded by Kv1.5 channels [103]. It is also localized mostly in
lipid rafts, which lack caveolin-3 [104], pointing to the extracaveolae compartment (however, see also [105,106], where
localization of Kv1.5 channels is debated). Similar to the Heijman
et al. model [8], we put the IKur current in the extracaveolae
compartment.
Stimulation of b1-ARs increases the function of IKur [107].
Figure 13A show an experimental time course of IKur activation in
human atrial myocytes upon application of 1 mM isoproterenol
(solid lines with circles, [107]). We adjusted model parameters and
performed simulations to fit the experimental time behavior (solid
line in Fig. 13A). Our model also reproduced an increase in IKur at
different concentrations of isoproterenol (Fig. 13B). The saturation
of the current amplitude found experimentally is observed at
isoproterenol concentrations of 0.1 to 1 mM (solid lines with circles
[108]). Similar data is obtained from simulations (solid line in
Fig. 13B).
Experimental voltage dependence of the peak ultra-rapidly
activating delayed rectifier K+ current in response to depolarizations in the interval from 240 to +50 mV for control conditions
and after application of 1 mM isoproterenol is shown in Fig. 13C
[107]. As in [25], simulated data show activation of IKur at slightly
more hyperpolarized potentials to offset the effects of divalent
cations, which are used in the experiments to block ICaL. However,
both simulated and experimental data show similar increases in
peak current amplitude upon stimulation of b1-ARs (solid and
dashed lines in Fig. 13C).
Rapidly recovering transient outward K+ current
module. The other substrate of PKA in the extracaveolae
PLOS ONE | www.plosone.org
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b1-adrenergic signaling system leads to an increased phosphorylation of PLB by PKA, resulting in an increase in the SERCA
pumping rate of Ca2+ from the cytosol to the SR. Dephosphorylation of PLB occurs by protein phosphatase 1 only [59,115].
Figure 14A shows experimental and simulated time courses of
PLB phosphorylation (in %) after stimulation of the b1-adrenergic
signaling system. Experimental data were obtained from rat hearts
by application of 0.5 mM PKA catalytic subunit (unfilled squares,
[116]) or 1 mM isoproterenol (filled circles, [117]). Data of Li et al.
[118] obtained from mouse ventricular myocytes with application
of 1 mM isoproterenol is shown by unfilled circles. Phosphorylation
occurs rapidly, within one to two minutes of exposure to agonists.
The time course is reasonably well reproduced by the model (solid
line in Fig. 14A).
Relative phosphorylation levels of PLB after stimulation with
different concentrations of isoproterenol are shown in Fig. 14B.
Experimental data obtained from rat [116,117] and guinea pig
[119] hearts and from rat ventricular myocytes [120] consistently
show similar half-activation isoproterenol concentration in the
range from 0.003 to 0.01 mM. A similar dependence of PLB
phosphorylation levels is obtained from the model after 2-minute
exposure to different concentrations of isoproterenol (solid line in
Fig. 14B).
Troponin I module. Troponin I (inhibitory subunit of
troponin complex) is the second substrate that is phosphorylated
by PKA in the cytosolic compartment [27]. Phosphorylation of
troponin I increases the Ca2+ unbinding rate by 50% [121],
thereby decreasing the corresponding dissociation constant.
Dephosphorylation of troponin I occurs by protein phosphatase
2A [61,115].
Figure 14C shows experimental and simulated data of the time
course of the relative phosphorylation level of troponin I for mouse
ventricular myocytes. Experimental data were obtained by Li et al.
[118] upon stimulation of cardiac cells with 1 mM isoproterenol.
Both experimental and simulated data demonstrate a significant
phosphorylation level of TnI without stimulation of the b1adrenergic signaling system. Upon application of isoproterenol,
both experimental data and simulations show saturating TnI
phosphorylation levels within 2 minutes of stimulation (Fig. 14C).
Dependence of the relative phosphorylation level of TnI as a
function of isoproterenol concentration is shown in Fig. 14D. Both
our simulations and experimental data obtained by Sulakhe and Vo
[120] show a significant phosphorylation level of TnI at very low
concentrations of isoproterenol. Data also demonstrates that
0.1 mM isoproterenol causes almost complete TnI phosphorylation.

Method of Simulation
The resulting model contains 141 ordinary differential equations solved by a fourth-order Runge-Kutta method, with different
time steps. A relatively small time step of 0.000002 ms is used
during the 10 milliseconds after the initiation of the stimulus
current; the rest of the time, the time step is 0.0001 ms. Such small
time steps are mainly determined by the very fast activation time
constants of ryanodine receptors [25,122]. For simulation of the
cellular behavior without electrical stimulation the time step of
0.1 ms is used. The model is implemented as a program code in
FORTRAN 90, which runs on a single processor under SUSE
Linux 11 on a Dell Precision Workstation T3500 with six-core
Intel Xeon CPU W3670 (3.2 GHz, 12 GB RAM). Simulation of
one second of the activity of an electrically stimulated cell runs
approximately 3 minutes on this workstation. All model equations,
model parameters, and initial conditions are given in Appendix
S1. The model is developed for a room temperature of 25uC
(T = 298uK). Steady-state initial conditions were obtained by

Figure 12. The effects of b1-adrenoceptor stimulation on the
Na+-K+ pump. Panel A: Experimental time course of a relative
decrease in the intracellular [Na+]i concentration (filled circles) obtained
by Despa et al. [100] from mouse ventricular myocytes after application
of 1 mM isoproterenol and corresponding simulated time course of an
increase in relative phosphorylation level of phospholemman obtained
using our model (solid line). Panel B: Experimental data on a relative
increase in INaK current (filled circles) obtained by Gao et al. [101] from
guinea pig ventricular myocytes at different concentrations of
isoproterenol. Corresponding simulation data with our model on a
relative increase in phosphorylation of phospholemman is shown by a
solid line. Panel C: Experimental (black bars with errors [100]) and
simulated (gray bars) data on intracellular [Na+]i concentration before
(control) and after 10-minutes application of 1 mM isoproterenol (Iso).
doi:10.1371/journal.pone.0089113.g012
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Figure 13. The effects of b1-adrenoceptor stimulation on IKur and IKto,f. Panel A: Experimental time course of the relative increase in the
ultra-rapidly activating delayed-rectifier K+ current IKur obtained by Li et al. [107] from human atrial myocytes after application of 1 mM isoproterenol
(line with filled circles) and corresponding simulated time course of an increase in IKur obtained with our model (solid line). Simulation data is
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obtained with 200-ms pulses from a holding potential of 2100 mV to +40 mV at stimulation frequency 0.02 Hz. Panel B: Experimental data on a
relative increase in IKur current (filled circles) obtained by Yue et al. [108] from canine atrial myocytes at different concentrations of isoproterenol.
Corresponding simulation data with our model on relative increase in IKur are shown by a solid line. Simulation data is obtained with 4.5-s pulses from
a holding potential of 290 mV to 0 mV after 800-s exposure to different concentrations of isoproterenol. Panel C: Experimental (human atrial
myocytes [107], solid lines with circles) and simulated (solid and dashed lines) data on current-voltage relationships for IKur current. Experimental data
for control conditions and those obtained after application of 1 mM isoproterenol are shown by unfilled and filled circles, respectively. Simulated data
for control conditions are shown by a solid line, and 1 mM isoproterenol simulations are shown by a dashed line. Simulated currents are obtained by
4.5-s depolarizing pulses to between 280 and +50 mV (in 10-mV increment) from a holding potential of 290 mV. Panel D: Experimental time course
of the relative decrease in the rapidly recovering transient outward K+ current IKto,f obtained by Zhang et al. [111] from mouse Schwann cells after
application of 1 mM forskolin (filled circles) or 10 mM db-cAMP (unfilled circles), and corresponding simulated time course of a relative decrease in IKto,f
phosphorylation obtained with our model after stimulation with 10 mM isoproterenol (solid line). Panel E: Simulated time course of IKto,f traces
obtained by depolarization pulses to 25 mV from a holding potential of 2100 mV for control (solid line) and after stimulation with 10 mM
isoproterenol (dashed line). Panel F: Simulated data for G/Gmax (black lines) and steady-state inactivation relationships (gray lines) obtained for IKto,f
with two-pulse protocol (P1 stimuli from 2100 to +50 mV in 10 mV intervals for 500 ms, following P2 pulse to +50 mV for 500 ms; holding potential
is 2100 mV) in control (solid lines) and after application of 10 mM isoproterenol (dashed lines).
doi:10.1371/journal.pone.0089113.g013

with isoproterenol. In non-stimulated cells, cAMP concentrations
in caveolae, extracaveolae, and cytosol are equal to 0.2534 mM,
0.5079 mM, and 0.4078 mM, respectively. Such steady state
concentrations are determined by the balance between cAMP
production by adenylyl cyclases, cAMP degradation by phosphodiesterases, and cAMP fluxes between the compartments. The
steady-state concentrations of cAMP were obtained by running the
model equations without electrical stimulations until changes in
each variable did not exceed 0.01%. The steady-state distribution
of cAMP concentrations are qualitatively similar to the values
obtained by Iancu et al. [13] and Heijman et al. [8]. Iancu et al.
[13] data gives 0.1 mM and 1 mM of caveolar and cellular cAMP
concentrations; Heijman et al. [8] data shows 0.3471 mM,
9.6236 mM, and 0.47408 mM of cAMP in the caveolae, extracaveolae, and cytosolic compartments, respectively. All simulated
cellular cAMP concentrations are close to the resting cellular
cAMP concentrations (, 0.5–1 mM) obtained experimentally
[52,53].
Figure 15A shows the simulated time courses of cAMP
concentrations in different subcellular compartments in response
to 1 mM isoproterenol. All cAMP transients show relatively fast
rising (time-to peak is 35–70 s) and initial decaying phases due to
the activation of ACs and PDEs (Fig. 15C), and relatively slow
decay due to desensitization of b1-ARs. The fastest cAMP
transient is observed in the caveolae compartment because of
the larger relative activities of ACs and PDEs in this compartment
(see Appendix S1). In caveolae, cAMP also decays to the smaller
quasi-steady-state values during desensitization of b1-ARs. In the
extracaveolae compartment, cAMP rises and decays somewhat
slower than in the caveolae compartment and approaches the
largest quasi-steady-state values at later times. cAMP transient in
the cytosolic compartment has the largest time-to-peak value and
the largest amplitude. It predominantly determines the behavior of
cAMP in the cardiac cell (thick solid line). Note that the cellular
cAMP concentration transient has a somewhat smaller amplitude
due to its normalization to the whole cell volume Vcell.
Figures 15C and 15D demonstrate major factors that affect
cAMP transient development. cAMP increases upon relatively fast
activation of adenylyl cyclases by the alpha subunit of the
stimulatory G protein (Gsa) in all subcellular compartments
(time-to-peak is ,10 s). This process is accompanied by activation
of phosphodiesterases, with some delay, due to the rising cAMP
concentration and phosphorylation of PDEs by catalytic subunits
of PKA. The interaction between ACs and PDEs reaches quasisteady-state by ,200 s, when their activities become close to each
other. The slower part of cAMP transient is determined by the
desensitization of b1-ARs when the concentration of Gsa decreases
due to its smaller production and faster re-association with Gsbc to
restore Gsabc. In addition to the interaction of ACs and PDEs,

running the model equations without electrical stimulations until
changes in each variable did not exceed 0.01%. To generate
action potentials, a stimulus current, Istim, was applied
(Istim = 80 pA/pF, tstim = 1 ms) with the frequencies from 1 to
5 Hz (electrical stimulation). Voltage-clamp protocols for ionic
currents are described in corresponding figure legends.

Results
In this paper, our model for action potential and Ca2+ dynamics
in an apical mouse cardiac cell [25,26] was extended to include
a b1-adrenergic signaling system by using, in considerable part,
the methodology from the previously published models
[8,10,11,12,13]. Unlike models [10,11,12], our model represents
a compartmentalized b1-adrenergic signaling system. While the
model of Hejiman et al. [8] also includes a compartmentalized
b1-adrenergic signaling system, it is developed for larger species
(dog) and is verified with a different set of experimental data. In
particular, our model differs from the Hejiman et al. model [8] in
the following: 1) our model was verified in significant part by the
experimental data from mice; 2) the model was developed for a
different species (mouse) and includes a significantly different set of
ionic currents; 3) the model considers non-zero phosphorylation
levels of the protein kinase A substrates before activation of the
b1-adrenergic signaling system; 4) the model includes additional
modulation of adenylyl cyclases by bc-subunits of stimulatory
G-protein, Gs; 5) the model data is compared in significant part
with both absolute and relative magnitudes of the activities of
major signaling molecules of the b1-adrenergic signaling system; 6)
the model includes two subpopulations of the L-type Ca2+
channels located both in the caveolae and extracaveolae
compartments; 7) ryanodine receptors are localized in the
extracaveolae compartment. Our model also differs from the
recently published Yang and Saucerman model [12] for mouse
ventricular myocytes in the following: 1) compartmentalization of
b1-adrenergic signaling system; 2) inclusion of different types of
adenylyl cyclases (AC4–7) and phosphodiesterases (PDE2–4), their
compartmentalization and specific regulation by drugs (e.g.,
rolipram, Ro 20–1724, cilostamide, milrione); 3) multicompartmental distribution of protein kinase A targets and the possibility
of their separate regulation by drugs; 4) the effects of b1aderenergic signaling system not only on Ca2+ dynamics, but also
on action potential.

cAMP Dynamics During Activation of b1-adrenergic
Signaling System: the Effects of Phosphodiesterases
First, we investigated the behavior of cAMP and PKA catalytic
subunit concentrations in different cellular compartments in
response to the activation of the b1-adrenergic signaling system
PLOS ONE | www.plosone.org
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Figure 14. The effects of b1-adrenoceptor stimulation on phospholamban and troponin I. Panel A: Experimental time courses of the
phospholamban phosphorylation (in %) obtained from rat hearts [116,117] and mouse ventricular myocytes [118]. Data Karczewski et al. [116] are
obtained with application of 0.5 mM PKA catalytic subunit; data Kuschel et al. [117] and Li et al. [118] are obtained with application of 1 mM
isoproterenol. Simulated time course of PLB phosphorylation is shown by a solid line. Panel B: PLB phosphorylation (in %) as functions of
isoproterenol concentration. Experimental data from rat hearts [116,117] were obtained after 2-minute exposure to isoproterenol; data from guinea
pig hearts [119] were obtained after 1-minute exposure to isoproterenol; and data from rat ventricular myocytes [120] were obtained after 3-minute
exposure to isoproterenol. Simulated data after 2-minute exposure to different concentrations of isoproterenol is shown by a solid line. Panel C:
Experimental time courses of the troponin I phosphorylation (in %) obtained from mouse ventricular myocytes [118] after application of 1 mM
isoproterenol. Simulated time course of troponin I phosphorylation is shown by a solid line. Panel D: Troponin I phosphorylation (in %) as functions
of isoproterenol concentration. Experimental data from rat ventricular myocytes [120] were obtained after 3-minute exposure to isoproterenol.
Simulated data after 2-minute exposure to different concentrations of isoproterenol is shown by a solid line.
doi:10.1371/journal.pone.0089113.g014

compartment (Fig. 15B). Concentrations of catalytic subunits of
PKA decay relatively slowly in extracaveolae and cytosolic
compartments (dashed and dotted lines in Fig. 15B, respectively)
compared to those in caveolae compartment (thin solid line in
Fig. 15B), despite the relatively fast decay of cAMP concentrations
in both caveolae and cytosol (Fig. 15A). Such relatively fast return
of cAMP and PKA concentrations to their resting values in
caveolae points to an important role of this compartment in the
fast cAMP-mediated signal transduction within the b1-adrenergic
signaling system.
In addition to control conditions, we also simulated the effects of
PDE3 and PDE4 inhibition on cAMP dynamics (Fig. 16). As there

cAMP fluxes between the subcellular compartments contribute to
cAMP transients (Fig. 15D). At early times, up to ,30 s, the
largest flux is from the caveolae to the cytosolic compartment,
which is determined by the largest rising rate of cAMP in caveolae.
Then this flux changes direction, and a significant amount of
cAMP flows from cytosol to caveolae (dashed line in Fig. 15D).
Smaller fluxes, from extracaveolae to caveolae and from cytosol to
extracaveolae, are also observed during this stage of activation of
b1-ARs.
In our model, in contrast to cAMP, PKA does not move
between the compartments. Its activation is determined by the
type of PKA (PKAI or PKAII) and the level of cAMP in each
PLOS ONE | www.plosone.org

20

February 2014 | Volume 9 | Issue 2 | e89113

Adrenergic Signaling in Mouse Myocytes

Figure 15. The effects of b1-adrenoceptor stimulation on the dynamics of cAMP and PKA. Panel A: Simulated time courses of cAMP
concentrations in caveolae (thin solid line), extracaveolae (dashed line), and cytosolic compartments (dotted line), and in the whole cell volume (bold
solid line) after application of 1 mM isoproterenol. Panel B: Simulated time courses of PKA catalytic subunit concentrations in caveolae (thin solid
line), extracaveolae (dashed line), and cytosolic compartments (dotted line), and in the whole cell volume (bold solid line) after application of 1 mM
isoproterenol. Panel C: Simulated time courses of cAMP production rate by adenylyl cyclases (solid line) and cAMP degradation rate by
phosphodiesterases (dashed line) after application of 1 mM isoproterenol. Panel D: Simulated time course of cAMP fluxes between caveolae and
extracaveolae (solid line), caveolae and cytosol (dashed line), and extracaveolae and cytosol (dotted line) after application of 1 mM isoproterenol.
Fluxes are normalized to the cell volume Vcell.
doi:10.1371/journal.pone.0089113.g015

experimentally whether such predicted effect will be observed in
mouse ventricular myocytes as well.
In another set of simulations, the cells were first affected by the
selective inhibitor of PDE3 (or PDE4), and then a pulse of 0.1 mM
isoproterenol was applied at t = 200 s for 30 s (thick solid line in
Fig. 16B). In the time interval from 0 to 200 s, the selective
inhibition of PDE3 or PDE4 (both by 90%) increases steady-state
cellular cAMP concentrations by ,35% and ,130% (Fig. 16B).
Pulsed application of isoproterenol produces relatively short cAMP
transients, which decay to the pre-pulse quasi-steady-state levels.
When PDE3 is selectively inhibited, cAMP transient amplitude is
equal to 0.6754 mM, which is ,17% larger than the cAMP
transient in control (0.5763 mM). Selective inhibition of PDE4
results in the larger cAMP transient of 0.9780 mM, or ,69.7%
larger than in control. Experimental data with pulsed application
of isoproterenol and selective inhibition of PDE3 and PDE4
obtained from rat ventricular myocytes show qualitatively similar

is no detailed experimental data on cAMP dynamics during PDE
inhibition in mouse ventricular myocytes, we compared qualitatively the simulated cellular response to the data obtained for rats
[123]. The data for rats shows that the selective inhibition of PDE3
by cilostamide has significantly smaller effects on cAMP transient
than the selective inhibition of PDE4 by Ro 20–1724. We
simulated two different methods of cAMP transient production
during inhibition of PDE3 or PDE4: with continuous and pulsed
application of 0.1 mM isoproterenol. Figure 16A shows that
continuous application of isoproterenol from t = 0 s with simultaneous selective inhibition of PDE3 (90% inhibition) leads to an
increase in peak cAMP transient by about 30%. In contrast,
simultaneous application of isoproterenol and selective inhibition
of PDE4 (90% inhibition) increases peak cAMP value by about
,150%. This result points to the primary role of PDE4 in cAMP
degradation compared to PDE3. Similar results were obtained
experimentally in rats [123,124]. It needs to be determined
PLOS ONE | www.plosone.org
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prolongs mouse action potential at different degrees of repolarization. Table 1 shows the comparison of the simulated prolongations of the action potentials with the experimental data. For
example, APD50 and APD90 are prolonged by 21.67% and
14.90%, respectively. The simulated data for APD50 prolongation
is close to the corresponding experimental data, 13.564% [126]
and 18% [125] prolongation, but somewhat smaller than 48%
prolongation obtained by Wang et al. [75]. In addition, the
simulated data for APD90 prolongation is within the experimental
data variation (567% [126], 9% [125], and 51% [75]).
It is remarkable that such relatively small AP prolongation due
to activation of b1-ARs is accompanied by significant changes in
underlying ionic currents (Fig. 17). Simulations elucidate the
mechanism of this prolongation. The four major currents are
responsible for the changes in AP shape at an early stage of
repolarization. The fast Na+ current, INa, changes only slightly,
which leads to a small increase in AP amplitude (from 114.3 mV
in control to 117.8 mV after Iso). The L-type Ca2+ current, ICaL,
increases almost twice upon stimulation of b1-ARs, and promotes
AP prolongation. There is also a decrease in the amplitude of the
rapidly recovering transient outward K+ current, IKto,f, which also
contributes to AP prolongation. An increase in the amplitude of
the ultrarapidly activating K+ current, IKur, is the major opposing
effect to AP prolongation, resulting in a relatively small total effect.
At 90% of repolarization, four other, relatively small currents
contribute to repolarization: the Na+/Ca2+ exchanger current,
INaCa, the time-independent K+ current, IK1, the Na+/K+ pump,
INaK, and the Na+ background current, INab. (Fig. 17, D and E).
Significant increase in the magnitude of INaCa current upon
application of isoproterenol (Fig. 17E) is one of the additional
factors that cause action potential prolongation at 90%
repolarization.
Simulation data obtained at stimulation frequency 5 Hz (Fig. 17,
F–J) shows very similar behavior to the data for 1 Hz. The only
Table 1. Simulated and experimental prolongations (in %) of
the action potentials in mouse ventricular myocytes at
different repolarizations and stimulation frequencies (1 mM
Iso).

Figure 16. The effects of PDE3 and PDE4 inhibition on cAMP
dynamics upon activation of b1-adrenergic receptors. Panel A:
Simulated time courses of cellular cAMP concentrations for control
conditions (solid line), upon inhibition of PDE3 (dashed line), and upon
inhibition of PDE4 (dotted line) after sustained application of 0.1 mM
isoproterenol at time moment t = 0 s. Activities of PDE3 or PDE4 are
inhibited by 90% to simulate the effects of corresponding selective
inhibitors, cilostamide or milrione for PDE3, or rolipam or Ro 20–1724
for PDE4. Panel B: Simulated time courses of cellular cAMP
concentrations for control conditions (solid line), upon inhibition of
PDE3 (dashed line), and upon inhibition of PDE4 (dotted line) after
pulsed application of 0.1 mM isoproterenol at time moment t = 200 s for
30 s (thick solid line). The degrees of inhibition of PDE3 and PDE4 are
the same as in Panel A.
doi:10.1371/journal.pone.0089113.g016

APD25,
ms

APD50,
ms

APD75,
ms

APD90,
ms

Experimental
values

behavior [123]. Further experiments are necessary to determine
whether similar effects can be observed in mice.

Wu et al. [126] *

13.564

567

Tong et al. [125] **

18

9

Tong et al. [125] ***

38

28

Wang et al. [75]
****

48

51

Simulated values
(this paper)

The Effects of Activation of the b1-adrenergic Signaling
System on Mouse Action Potential

1 Hz

7.65

21.67

19.10

14.90

2 Hz

8.09

22.58

17.20

15.95

Experimental data obtained from mouse ventricular myocytes
shows that the activation of the b1-adrenergic signaling system
affects action potential shape and duration [75,125,126]. To
simulate these effects, we stimulated the model cell with current
pulses (Istim = 80 pA/pF, tstim = 1.0 ms) at frequencies 1 and 5 Hz
for 300 s without and with application of 1 mM isoproterenol.
Figure 17A shows corresponding action potentials obtained by
1 Hz stimulation. Simulated data shows that isoproterenol

3 Hz

9.14

24.76

18.77

16.73

4 Hz

9.04

26.09

18.04

13,16

5 Hz

8.33

27.27

17.00

10.37
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* Experimental data are obtained at 0.5 Hz stimulation and 2 mM isoproterenol.
** Experimental data are obtained at 2 Hz stimulation.
*** Experimental data are obtained at 4 Hz stimulation.
**** Experimental data are obtained at 1 Hz stimulation.
doi:10.1371/journal.pone.0089113.t001
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Figure 17. Simulated action potentials and underlying ionic currents of the isolated ventricular cell model. Simulated action potentials
and underlying ionic currents are shown for control conditions and after application of 1 mM isoproterenol at two pacing frequencies 1 Hz (Panels
A–E) and 5 Hz (Panels F–J) (Istim = 80 pA/pF, tstim = 1.0 ms). Panels A and F: Simulated action potentials for control conditions (solid line) and after
isoproterenol application (dashed line). Panels B, D, G, and I: Currents underlying the AP for control condition. Panel C, E, H, and J: Currents
underlying the AP after isoproterenol application. The scales for the relatively large fast Na+ current, INa, are given on the right axis in Panels B, C, G
and H. APs and ionic currents are shown after 300 s stimulation. In Panels A, C, E, F, H, and J 1 mM isoproterenol is applied at time t = 0 s.
doi:10.1371/journal.pone.0089113.g017

significant change is in the peak amplitudes of the fast Na+ current,
INa, which are decreased during stimulation with 5 Hz. A smaller
decrease is observed for K+ currents IKto,f and IKur at 5-Hz
stimulations. Simulation of application of 1 mM isoproterenol at
5 Hz stimulation prolongs APD50 and APD90 by 27.27% and
10.37%, respectively (Table 1). These prolongations are compared
to the experimental data of Tong et al. [125] obtained at 4 Hz
stimulation (38% and 28% prolongation for APD50 and APD90,
respectively). Simulation data shows a correct trend of APD50
prolongation, which increases with stimulation frequency. However, simulated prolongation of APD90 at 5 Hz-stimulation shows
somewhat smaller magnitude compared to 4 Hz-data of Tong
et al. [125].
We have also simulated the effects of isoproterenol on action
potential durations (APDs) at the frequencies ranged from 1 to
5 Hz. Simulation data shows relatively small increase in APDs at
different levels of repolarization with stimulation frequency. For
example, without isoproterenol, APD50 changes from 3.0 to
3.3 ms and APD90 changes from 25.5 to 27.0 ms when stimulation
frequency increases from 1 to 5 Hz. Upon exposure to isoproterenol, APD50 increases from 3.65 to 4.2 ms and APD90 ranges from
29.3 to 30.7 ms during the same increase in stimulation frequency.
Prolongation of cardiac action potential durations upon application of isoproterenol is consistently observed experimentally in
mouse ventricular myocytes [75,125,126] (Table 1).

however, that the absolute values of [Ca2+]i relaxation constants
obtained by Wang et al. [75] without and with isoproterenol are
significantly longer, 267 and 147 ms, respectively, but their ratio
(,1.8) is very close to the corresponding simulated value.
Our model allows for evaluation of various Ca2+ fluxes and their
modifications by isoproterenol. Figure 19 shows simulated Ca2+
fluxes obtained at 1 and 5 Hz stimulations without and with 1 mM
isoproterenol. Simulations show that the activation of the
b1-adrenergic signaling system leads to a significant increase in
Ca2+ influx through the L-type Ca2+ channels during action
potential from 1.6 mM (4.5% of released Ca2+ from the SR) to
3.3 mM (5.3%) at 1 Hz and from 1.8 mM (5.5%) to 3.5 mM (7.6%)
at 5 Hz during cardiac cycles. Increase in Ca2+ influx results in an
increase in the SR Ca2+ load, from 919 mM to 1860 mM at 1 Hz
(Fig. 19E, an increase which is comparable to the experimental
findings [128,129,132]), resulting in a growth of Ca2+-induced
Ca2+ release from 36 mM to 61 mM. Smaller increase in the SR
Ca2+ load is obtained at 5 Hz, from 1367 mM to 1602 mM, which
results in an increase of Ca2+ release from 32 mM to 46 mM. An
increase in intracellular [Ca2+]i transients after application of
isoproterenol also increases Ca2+ extrusion from the cytosol by the
Na+/Ca2+ exchanger from 3.1 mM (8.6%) to 4.6 mM (7.6%) at
1 Hz and from 1.9 mM (6.0%) to 3.6 mM (7.8%) at 5 Hz; however,
this increase does not completely compensate for the Ca2+ entry
into the cell, which ultimately leads to an increase in the SR Ca2+
load. Only 0.18 mM and 0.28 mM (1 Hz stimulation) and 0.16 mM
and 0.22 mM (5 Hz stimulation) of Ca2+ are extruded from the cell
by a slow mechanism through the sarcolemmal Ca2+ pump for
control conditions and after application of isoproterenol, respectively, which is about 0.5% of the released Ca2+ in all cases. Our
model also includes background Ca2+ influx of ,1.7 mM (1 Hz)
and ,0.3 mM (5 Hz) due to a very large Ca2+ gradient across the
membrane, which does not change upon stimulation of b1-ARs.
Figure 20 shows the time behavior of the peak values of
intracellular [Ca2+]i transients and intracellular [Na+]i concentration for control conditions and after application of 1 mM
isoproterenol upon stimulation with frequency 1 Hz. In control,
[Ca2+]i transients approach quasi-steady-state values after a shorttime initial decay (negative staircase effect). After application of
isoproterenol, [Ca2+]i transients relatively rapidly increase in
amplitude during the first ,300 seconds, and then they slowly
decay. Such behavior of [Ca2+]i transients is similar to the
experimental data obtained by Despa et al. [127]. Initial increase
in [Ca2+]i transients is due to the rapid activation of
b1-adrenoceptors and cAMP accumulation; relatively slow decay
of peak [Ca2+]i is due to b1-adrenoceptors desensitization. In
addition, Despa et al. [127] have shown that the stimulation of b1ARs decreases intracellular [Na+]i concentration due to an
increased function of the Na+-K+ pump. Our simulation data
reproduced this behavior. In control, stimulation of the model cell
leads to a slight increase in [Na+]i to saturating values (solid line in
Fig. 20B). However, the behavior of [Na+]i changes after
application of isoproterenol (dashed line in Fig. 20B): after a small
initial increase until peak value, [Na+]i decreases subsequently in
time until quasi-steady-state level. Simulated [Na+]i concentration
begins to decay at approximately the same time as [Ca2+]i achieves

The Effects of Activation of the b1-adrenergic Signaling
System on Ca2+ Dynamics
Experimental data obtained with micromolar concentrations of
isoproterenol demonstrates significant (up to 5-fold) increase in
intracellular [Ca2+]i transients obtained from mouse ventricular
myocytes (Fig. 18, [75,127,128,129]). Our simulations are able to
reproduce this behavior. Figure 18, A and B, shows simulated
[Ca2+]i transients, obtained without and with 1 mM isoproterenol
at stimulation frequencies 1 and 5 Hz. Stimulation of the b1adrenergic signaling system increases the simulated amplitudes of
[Ca2+]i at 1 Hz-stimulation from 0.44 mM to 1.92 mM (Fig. 18A),
or by 4.33 fold. At larger stimulation frequency 5 Hz, [Ca2+]i
increases from 0.66 mM to 1.85 mM (Fig. 18B), or by 2.79 fold.
These values are in good agreement with the experimental data
[75,127,128,129], which ranges from 2.3 to 5.2-folds increase.
Frequency dependence of the diastolic and systolic [Ca2+]i
(Fig. 18C) demonstrates an increase of their magnitudes, with
the exclusion of peak [Ca2+]i at 1 mM isoproterenol and
stimulation frequencies 4 and 5 Hz. It is remarkable that the
model reproduces experimentally found feature such as independence of diastolic [Ca2+]i from the b1-adrenergic stimulation
[128,130].
Our model also provides appropriate time constants for the
decay of intracellular [Ca2+]i and corresponding acceleration of
the decay upon application of isoproterenol. Simulated and
experimental frequency dependences of the decay of intracellular
[Ca2+]i without and with 1 mM isoproterenol are shown in
Fig. 18D. The simulated time constants for the decay decrease
with the stimulation frequency without and with isoproterenol and
reasonably well approximate experimental data [128,131]. Note,
PLOS ONE | www.plosone.org
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Figure 18. Simulated and experimental [Ca2+]i transients and their characteristics in an isolated ventricular cell for control
conditions and after application of isoproterenol. Panel A: Simulated [Ca2+]i transients for control conditions (solid line) and after 1 mM
isoproterenol application (dashed line) obtained with 1 Hz-stimulation. Panel B: Simulated [Ca2+]i transients for control conditions (solid line) and
after 1 mM isoproterenol application (dashed line) obtained with 5 Hz-stimulation. Panel C: Simulated diastolic (filled symbols) and systolic (unfilled
symbols) [Ca2+]i magnitudes for control conditions (circles) and after 1 mM isoproterenol application (triangles) as functions of stimulation frequency.
Panel D: Decay time constants for intracellular [Ca2+]i transients for control conditions and after 1 mM isoproterenol application as functions of
stimulation frequency. Simulated data are shown by solid (control) and dashed (1 mM isoproterenol) lines. The lines with symbols show experimental
data from Benkunsky et al. [131]; experimental data from Knollmann et al. [128] are shown by squares. Panel E: Increase in [Ca2+]i transient
amplitudes after application of isoproterenol (folds). Model data and data of Wang et al. [75] and Liu et al. [129] are obtained at 1 Hz and 1 mM
isoproterenol; data of Despa et al. [127] are obtained at 2 Hz and 1 mM isoproterenol; data of Knollmann et al. [128] are obtained at 1 Hz and 0.5 mM
isoproterenol. All simulation data in this figure are obtained after 300-s stimulations and exposure to 1 mM isoproterenol.
doi:10.1371/journal.pone.0089113.g018
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Figure 19. Ca2+ fluxes and the SR Ca2+ load. Simulated major integral Ca2+ fluxes during one cardiac cycle in the isolated ventricular cell model
for control conditions (Panels A and C) and after application of 1 mM isoproterenol (Panels B and D). Pacing frequencies are 1 Hz (Panels A and
B) and 5 Hz (Panels C and D). Major integral Ca2+ fluxes are shown after 300 s of stimulation. In Panels B and D 1 mM isoproterenol is applied at
time t = 0 s. Here, JCaL is the Ca2+ entering the cell through L-type Ca2+ channels; Jup – Jleak is the uptake Ca2+ from the cytosol to the network SR with
subtracted Ca2+ leak from the SR to the cytosol; JNaCa is the Ca2+ outflux from the cytosol through the Na+/Ca2+ exchanger; and JpCa is the Ca2+ outflux
through the sarcolemmal Ca2+ pump. Panel E: Increase in the SR Ca2+ load after 300-s application of isoproterenol. Model data are shown for
stimulation frequencies 1, 2, 3, 4, and 5 Hz; experimental data of Liu et al. [129] and Fernandez-Velasco et al. [132] are obtained at 1 mM
isoproterenol; data of Knollmann et al. [128] are obtained at 0.5 mM isoproterenol.
doi:10.1371/journal.pone.0089113.g019

its maximum value. Experimental data shows a plateau in
concentration of [Na+]i for a short time after application of
isoproterenol, which is replaced by a decay after [Ca2+]i achieves
the maximum value [127].
Finally, experimental data demonstrates the absence of the
negative staircase effect in [Ca2+]i transients which are elicited by
stimulation of a quiescent cell after application of isoproterenol
[27]. The experimental data are obtained for rat ventricular
myocytes, whose Ca2+ handling system is similar to that for mice.
PLOS ONE | www.plosone.org

Our model for mouse ventricular myocytes reproduced this
behavior. Figure 21A shows [Ca2+]i transients upon stimulation of
the quiescent cell with the frequency of 1 Hz in the control cell.
The [Ca2+]i decrease in time, clearly shows a negative staircase
effect. In another simulation (Fig. 21B), 1 mM isoproterenol is
applied to the quiescent cell for 600 seconds, and then the cell is
electrically stimulated with the frequency of 1 Hz. The simulation
data does not show a decrease in [Ca2+]i transient amplitudes,
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Figure 21. The effects of isoproterenol on negative staircase of
[Ca2+]i transients. Panel A: Simulated [Ca2+]i transients as function of
time for control conditions show clear negative staircase effect. Panel
B: Simulated [Ca2+]i transients as function of time after 1 mM
isoproterenol application at t = 0 s does not show negative staircase
effect. In both panels, stimulation frequency is 1 Hz.
doi:10.1371/journal.pone.0089113.g021

The Effects of Activation of the b1-adrenergic Signaling
System on Na+ Fluxes
Experimental data shows the effects of the b1-adrenergic
signaling system on Na+ dynamics in ventricular myocytes
[100,127]. In particular, in mouse ventricular myocytes, [Na+]i
decreases upon stimulation of b1-adrenergic receptors. Such
behavior was reproduced by our model as well (Fig. 20B). In
addition, our model is able to predict major Na+ fluxes into and
out of the mouse ventricular myocytes. Simulated Na+ fluxes for
control conditions and after application of 1 mM isoproterenol for
stimulation frequencies of 1 and 5 Hz (Istim = 80 pA/pF,
tstim = 1 ms) are shown in Fig. 22. Na+ enters the cell through
the fast Na+ channels, Na+/Ca2+ exchanger, and background
mechanisms (large Na+ gradient and other exchangers and cotransporters [133]), and is pumped out of the cell by the Na+-K+
pump. Without isoproterenol and at 1 Hz stimulation, 3.8 mM of
Na+ enter the cell during action potential through the fast Na+
channels (6.5% of the total Na+ influx), 9.3 mM of Na+ through the
Na+/Ca2+ exchanger (16%), and 45.5 mM of Na+ through the
background mechanism (77.5%), giving total Na+ influx of
58.6 mM. After application of 1 mM isoproterenol and 1 Hz
stimulation, the total Na+ influx into the cell increases to 64.0 mM,
resulting in proportional changes of Na+ influx through the fast
Na+ channels (4.2 mM, or 6.5%), increased influx through the
Na+/Ca2+ exchanger (13.9 mM, or 22%), and unchanged Na+
influx through the background mechanism (45.9 mM, or 71.5%).
At the larger stimulation frequency (5 Hz), the contribution of the
different Na+ entry mechanisms changes. Without isoproterenol,
3.6 mM of Na+ enter the cell during action potential through
the fast Na+ channels (20% of the total Na+ influx), 5.8 mM of
Na+ through the Na+/Ca2+ exchanger (32%), and 8.9 mM of Na+
through the background mechanism (48%), yielding total Na+

Figure 20. Dynamics of [Ca2+]i transients and [Na+]i concentrations upon stimulation of b1-adrenoceptors. Panel A: Simulated
peak values of [Ca2+]i transient as function of time for control conditions
(solid line) and after 1 mM isoproterenol application at t = 0 s (dashed
line). Panel B: Simulated intracellular [Na+]i concentrations as function
of time for control conditions (solid line) and after 1 mM isoproterenol
application at t = 0 s (dashed line). In both panels, stimulation frequency
is 1 Hz.
doi:10.1371/journal.pone.0089113.g020

thereby confirming the absence of a negative staircase effect after
stimulation of the b1-adrenergic signaling system.
The mechanism of two different types of behavior is explained
by the analysis of the input and output Ca2+ fluxes without and
with application of isoproterenol. Our simulations of the case
without isoproterenol show that the stimulation of the quiescent
myocyte increases total intracellular Ca2+ loss and decreases the
SR Ca2+ load, resulting in continuous decrease in [Ca2+]i transient
(Fig. 21A). If the simulated cell is first pretreated with isoproterenol
in the quiescent state for 600 seconds and then the electrical
stimulation is applied, the Ca2+ fluxes inside and outside the cell
remain balanced due to the predominant increase in the L-type
Ca2+ current. The result is that the SR Ca2+ load is not decreased,
resulting in the absence of negative staircase effect.
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Figure 22. The effects of isoproterenol on integral Na+ fluxes. Simulated major integral Na+ fluxes during one cardiac cycle in the isolated
ventricular cell model are shown for control conditions (Panels A and C) and after application of 1 mM isoproterenol (Panels B and D). Pacing
frequencies are 1 Hz (Panels A and B) and 5 Hz (Panels C and D). Major integral Na+ fluxes are shown after 300 s of stimulation. In Panels B and
D 1 mM isoproterenol is applied at time t = 0 s. Here, JNav is the Na+ entering the caveolae compartment through the fast Na+ channels; JNab is the
background Na+ influx; JNaCa is the Na+ influx to the cytosol through the Na+/Ca2+ exchanger; and JNaK is the Na+ outflux through the Na+-K+ pump.
doi:10.1371/journal.pone.0089113.g022

influx of 18.3 mM. Application of 1 mM isoproterenol increases the
total Na+ influx into the cell to 24.4 mM, resulting in an increase of
Na+ influx through the fast Na+ channels (3.9 mM, or 17%) and
the Na+/Ca2+ exchanger (10.7 mM, or 46%), and unchanged Na+
influx through the background mechanism (8.9 mM, or 37%).
Thus, our simulations allow for the estimation of Na+ fluxes and
dynamics, and their modifications by the b1-adrenergic signaling
system. The model data shows an increased fraction of voltagedependent Na+ entry into the cell at higher stimulation frequencies
and the shift of the balance of the Na+ fluxes upon application of
isoproterenol towards outside the cell due to an increased function
of the Na+-K+ pump.

1 mM isoproterenol (Fig. 23). The model cells are electrically
stimulated at the frequency 1 Hz. In control, we observed a little
change in action potential shape when the caveolae-linked ICaL
(ICaL,cav) is blocked (APD50 decreased by only 2%), whereas a
much larger change in the AP is observed during block of ICaL in
the extracaveolae compartment (ICaL,ecav) (APD50 decreased by
14%) (Fig. 23, A). The magnitude of the total ICaL changed by
,20% during the block of ICaL,cav, while the ICaL is almost
abolished by the block of ICaL,ecav (Fig. 23, B). The ICaL,cav block
relatively slightly (by 25%) decreases [Ca2+]i transients, similar to
the experimental finding by [70], while at the ICaL,ecav block such
transient is not present (Fig. 23, C).
When the model cell is stimulated by isoproterenol, the specific
block of ICaL,cav only slightly decreased the total cellular ICaL
(Fig. 23, E), resulting in more pronounced shortening of APD50 (by
8%, Fig. 23, D) compared to control. Even larger AP shortening is
obtained with the specific block of ICaL,ecav (by 28%). More
significant effect of ICaL,cav block on [Ca2+]i transients is predicted
by simulations with isoproterenol than for control conditions (a
decrease by 28%), and [Ca2+]i transients is almost abolished with
the ICaL,ecav block (Fig. 23, F). Further experiments on the effects
of different populations of the L-type Ca2+ channels on the action
potential and [Ca2+]i transients are necessary to verify model
predictions.

The Effects of the Block of Different Populations of ICaL on
the Action Potential and [Ca2+]i Transients
Experimental data shows that two different populations of the
L-type Ca2+ channels, in caveolin-3-rich and caveolin-3-free
membrane fractions, affects differently [Ca2+]i transients and
cellular contraction [70]. Such investigations were performed by a
specific block of the caveolae-linked L-type Ca2+ channels. While
the experiments show a 10% decrease in the mean values of the
peak of [Ca2+]i transients in the myocytes with blocked caveolaelocated L-type Ca2+ channels compared to control, such decrease
did not reach statistical significance. Similar small, but not
significant, decrease was also observed in myocyte contraction.
We used the model to investigate the effects of the L-type Ca2+
channel block in different cellular compartments on the action
potential and [Ca2+]i transients in control and after application of
PLOS ONE | www.plosone.org

Discussion
In this paper, a new compartmentalized model for the
b1-adrenergic signaling system in mouse ventricular myocytes is
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Figure 23. The effects of two subpopulations of the L-type Ca2+ current block on the action potentials and [Ca2+]i transients.
Simulated effects of two subpopulations of the L-type Ca2+ current block on the action potentials and [Ca2+]i transients in the isolated ventricular cell
model are shown for control conditions and after application of 1 mM isoproterenol at pacing frequency 1 Hz (Istim = 80 pA/pF, tstim = 1.0 ms). Panels
A–C: Control conditions; Panels D–F: Isoproterenol is applied. Panels A and D: Simulated action potentials for control conditions (solid black line),
after ICaL,ecav block (green line), and after ICaL,cav block (red line). Panels B and E: Simulated ICaL currents. Panel C and F: Simulated [Ca2+]i transients.
APs and ionic currents are shown after 300 s stimulation. 1 mM isoproterenol is applied at time t = 0 s.
doi:10.1371/journal.pone.0089113.g023

reproduces cAMP dynamics, activation of adenylyl cyclases and
phosphodiesterases, protein kinase A and its targets, voltage-clamp
protocols for major repolarization currents, action potential
modification, and changes in the Ca2+ handling mechanism upon
stimulation of the b1-adrenergic signaling system. The model
allows for elucidation of the mechanisms of action potential

developed. This model is based on our previously published model
for an apical cardiac cell [25,26], which includes a comprehensive
description of action potential, ionic currents, and Ca2+ dynamics.
The new model includes biochemical and electrophysiological
parts of the b1-adrenergic signaling pathway, which are extensively
verified by the existing experimental data. The model successfully
PLOS ONE | www.plosone.org
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prolongation and increase in [Ca2+]i transients. Simulations also
show the absence of the negative staircase effect in [Ca2+]i
transients upon stimulation of b1-adrenoceptors, which was found
experimentally. The model also allows for some testable predictions, such as frequency dependences of action potential durations
and [Ca2+]i transient amplitudes. The model highlights the
importance of compartmentalization of the b1-adrenergic signaling system in mouse ventricular myocytes by the description of the
two populations of the L-type Ca2+ channels, in caveolae and
extracaveolae compartments, and their distinct functional role in
myocyte function, as well as the differential localization and
function of other PKA targets.

Methods for details). It is remarkable that one of the PKA targets,
the L-type Ca2+ channel, is expressed in both the caveolae and
extracaveolae compartments, with different a physiological role in
each domain. In addition to the different distribution of two major
protein kinase A isoforms (PKAI and PKAII), there is also a
different localization of the major dephosphorylation proteins
(protein phosphatase 1 and protein phosphatase 2A). Both PP1
and PP2A are found in the caveolae and cytosolic compartments,
however, only PP1 plays an important functional role in the
extracaveolae. Such distribution of the targets results in their
different phosphorylation kinetics and magnitude, producing a
very complex interaction relationship in the effects on action
potential and [Ca2+]i transients.
Our model of the b1-adrenergic signaling system includes
differential subcellular localization of both signaling and target
proteins, and is able to reproduce both phosphorylation kinetics
and concentration-dependence of protein phosphorylation by
isoproterenol (see Methods). Several non-compartmentalized
models were developed for b1-adrenergic signaling system in
different species, including mice [9,10,11,12]. The models were
extensively verified by the available experimental data on the
effects of activation of b1-adrenergic receptors on electrical activity
and ionic homeostasis. However, as the experimental technique is
improving and the new data on subcellular organization of
signaling systems is accumulating, more comprehensive models are
required for more precise description of the cellular functions.
Such important findings include differential localization of the
isoforms of the major signaling proteins in the b1-adrenergic
signaling system: adenylyl cyclases, phosphodiesterases, and
protein kinase A [10,36,46]. Discovery of the differential
localization of the targets of PKA, such as the ionic currents and
contractile proteins, requires more demands on the models of
cardiac cells to include multiple subcellular compartments. One of
the recent experimental findings of the two populations of the
L-type Ca2+ channels, the major players in cardiac excitationcontraction coupling, and their differential physiological role in
cellular function highlights the needs in compartmentalized
models of cardiac myocytes [21,22]. One such model was
developed recently for canine ventricular myocytes and includes
three signaling systems, b1- and b2-adrenergic, and CaMKIImediated signaling systems [8]. The model described well
extensive experimental data and the effects of different signaling
systems on the cardiac action potential and [Ca2+]i transients. Our
model of the b1-adrenergic signaling system consists of some
elements of the model of Heijman et al. [8], but with significant
differences, as outlined above. In particular, the presented model
includes different localization of ryanodine receptors and describes
two populations of the L-type Ca2+ channels based on the most
recent experimental data [21,22]. While the major role of
compartmentalization of the components in the b1-adrenergic
signaling system is clear – separation of the effects of different
signaling proteins – the particular role of the signaling molecules in
the mechanisms of regulation of the target proteins still needs to be
determined.

Compartmentalization of the b1-adrenergic Signaling
System
The b-adrenergic signaling system plays a significant role in the
function of the heart. There are two types of b-adrenergic
receptors in cardiomyocytes (b1- and b2-adrenergic receptors),
which are different in their cellular localization and function.
Experimental data from rat ventricular myocytes by Rybin et al.
[20] shows that b1-adrenergic receptors are distributed between
caveolae, non-caveolae membrane fractions, and internal membranes, with the majority of the b1-adrenergic receptors being
found outside of the caveolae compartment. In contrast,
b2-adrenergic receptors (b2-ARs) are localized in the caveolae
compartment [20]. Similar data were obtained for mouse
ventricular myocytes [19]. According to the experimental finding,
our model includes only 1% of b1-adrenergic receptors in the
caveolae compartment, with the majority of them distributed
between the extracaveolae and cytosolic compartments. Such
localization suggests different functional consequences: selective
activation of b1-adrenergic receptors with isoproterenol in mouse
ventricular myocytes leads to a significant increase in [Ca2+]i
transient and myocyte contraction, while selective activation of b2adrenergic receptors with zinterol does not have any effect on
myocyte contractility [134]. Activation of b1-adrenergic receptors
also results in phosphorylation of major cytosolic proteins, such as
phospholamban and troponin I, while stimulation of b2-adrenergic
receptors does not produce this effect [135].
In addition to differential localization of b1- and b2-adrenergic
receptors, experimental data also demonstrates differential localization of signaling proteins involved in the b1-adrenergic signaling
pathway, suggesting that even activation of one signaling system is
a complex process, which proceeds differently in separate
compartments. It has been found that adenylyl cyclases of type
V/VI are predominantly localized in caveolae, while types IV and
VII are located in non-caveolae membrane fractions and cytosol
[28,35,36]. There is also differential distribution of three major
types of phosphodiesterases in subcellular compartments (PDE2,
PDE3, and PDE4 [48]), which also causes different effects on
cAMP degradation [123]. Our model successfully reproduces the
activities of ACs and PDEs in different compartments, and the
differential effects of PDE3 and PDE4 inhibition in production of
cAMP transients. For example, steady-state cAMP concentration
is smaller and cAMP transient is less prolonged in the caveolae
compartment than in the extracaveolae and cytosol (Fig. 15),
suggesting larger activity of PDEs in the caveolae.
Finally, the major protein kinase A phosphorylation targets are
also localized in different subcellular compartments. Two of them
are found predominantly in the caveolae compartment (the fast
Na+ current and the phospholemman, which regulates the Na+-K+
pump), five others (ICaL, IKto,f, IKur, IK1, and ryanodine receptors)
are predominantly expressed in non-caveolae membrane domains,
and phospholamban and troponin I are located in the cytosol (see
PLOS ONE | www.plosone.org

The Effects of the b1-adrenergic Signaling System on
Action Potential
Experimental data shows that the activation of the
b1-adrenergic signaling system moderately prolongs action potentials duration in mouse ventricular myocytes (Table 1, [125,126]).
Our previous simulation data using the models of mouse
ventricular myocytes and ventricular tissues show that the
prolongation of action potential can be a pro-arrhythmic factor
causing a loss of stability at the cellular level [136] or action
30
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potential block at the tissue level at fast pacing rates [137]. Our
model reproduces action potential prolongation and elucidates its
mechanism. We found that the major effect on action potential at
25% and 50% repolarization comes from an increase in the
inward L-type Ca2+ current, ICaL, and the fast Na+ current, INa,
and a decrease in the rapidly recovering transient outward K+
current, IKto,f, which tend to prolong action potential, and an
increase in the ultra-rapidly activating current, IKur, whose role is
in action potential shortening (Fig. 17). At 75% and 90%
repolarization, more currents, such as the Na+/Ca2+ exchanger
current, the Na+-K+ pump current, the time-independent K+
current, IK1, and the Na+ background current, INab, are brought
into play (Fig. 17). The total result of interaction is the moderate
prolongation of action potential duration. Note that similar
prolongation of the action potential duration upon stimulation of
the b1-adrenergic signaling system was found in rat ventricular
cells [10], however, the mechanism of the action potential
prolongation and the role of major contributing currents were
not investigated.
Frequency dependences of the action potential duration at
different levels of repolarization show their different prolongations
upon stimulation with isoproterenol (Table 1). While the
prolongations of APD50 increase with the stimulation frequency,
the prolongations of APD75 and APD90 demonstrate more
complex behavior. Such differences are explained by the different
major contributing currents to AP duration at different levels of
repolarization without and with isoproterenol. A decrease in the
prolongation magnitude of APD90 compared to APD50 upon
application of isoproterenol is also observed in some experiments
[125,126]; however, data of Wang et al. [75] demonstrated similar
prolongations both for APD90 and APD50. Further experiments
are necessary to investigate this phenomenon.
This effect of b1-adrenergic receptor stimulation on action
potential is different from that in larger species [8,11]. Experimental data shows that stimulation of b1-ARs reduces action
potential duration in rabbits and dogs wild type ventricular
myocytes [11,138]. The data of Volders et al. [138] shows that
one of the major contributing factors in action potential shortening
is an increase in the slow delayed-rectifier current, IKs, upon
activation of b1-ARs. The increase in IKs overcomes the tendency
of action potential to prolongation due to an increase in the L-type
Ca2+ current, ICaL [138]. This result was also confirmed by
simulations using models for rabbit and canine action potential
which include the b1-adrenergic signaling system [8,11].
Thus, our model for the b1-adrenergic signaling system in
mouse ventricular myocytes and the models of others for canine
and rabbit cardiac cells [8,11] demonstrate different effects of
b1-adrenoceptor stimulations on the action potential durations,
elucidate the mechanisms of these effects, and reveal the different
ionic currents which are responsible for the changes.

phosphorylation of phospholamban increases the pumping of
Ca2+ into the SR upon stimulation of b1-AR and is considered a
crucial regulator of cardiac function [27,141]. However, this
phospholamban phosphorylation is not the only reason for such
increase. Recently Eisner et al. [142] analyzed the major
contributing factor to positive cardiac inotropy upon stimulation
of b1-ARs. They considered four proteins that are affected by
adrenergic stimulation: ryanodine receptors, SERCA pump,
L-type Ca2+ channels, and troponin. Their analysis has shown
that the L-type Ca2+ current is a major player that leads to positive
cardiac inotropy. In our model, stimulation of the b1-adrenergic
signaling system increases ICaL by about twice compared to control
cells (Fig. 9 [79,80,81]). This increase approximately doubles Ca2+
influx into the myocyte (see also our simulation data in Fig. 19),
while Ca2+ extrusion from the myocyte, predominantly by the
Na+/Ca2+ exchanger, does not increase to the same degree. The
resulting effect is an increase in Ca2+ influx into cell until a new
dynamic quasi-steady-state is reached. Thus, our modeling data
supports the view that the L-type Ca2+ current is a major player in
cardiac inotropy in mouse ventricular myocytes, as also suggested
by Eisner et al. [142].
Our model also supports the idea that the key contributor to
cardiac lusitropy upon stimulation of b1-ARs is the SERCA Ca2+
pump. In mouse and rat ventricular myocytes, about 90% of the
released Ca2+ is pumped back to the sarcoplasmic reticulum
compared to about 70% in rabbits and larger species [27]. An
estimation of Ca2+ influx into the SR by the SERCA pump during
one cardiac cycle (1 Hz stimulation) before and after activation of
the b1-adrenergic signaling system is 36 mM and 61 mM,
respectively. This estimation correlates with about a two-fold
decrease in the time constant of [Ca2+]i relaxation (Fig. 18). While
the Na+/Ca2+ exchanger also contributes to the [Ca2+]i relaxation,
its contribution in mouse ventricular myocytes is less than 10%. In
larger species, the Na+/Ca2+ exchanger can make a larger
contribution to the lusitropic effect, as its share is about 25–30%
of the total released Ca2+.
There is also a long-term dispute among two groups of scientists
who study ryanodine receptors (Marks group on the one hand and
Valdivia and Houser group on the other) related to the
physiological role of RyR phosphorylation in cardiac function
[143]. Experimental data of Marks and co-authors demonstrated
that enhanced phosphorylation of RyRs at S2808 in failing hearts
results in an increased Ca2+ leak from the SR and leads to an
increased arrhythmias [143,144]. The Houser and Valdivia group
have shown opposite results: they found that RyR phosphorylation
site S2808 does not produce significant physiological effects
neither in wild type nor in infarcted mouse hearts [145]. Our
simulations shows that phosphorylation of RyRs does not change
Ca2+ sensitivity and does not produce significant physiological
effect during stimulation of the b1-adrenergic signaling system, the
results which are in line with the data from Houser and Valdivia
group.

The Effects of the b1-adrenergic Signaling System on
Ca2+ Dynamics

The Effects of the b1-adrenergic Signaling System on Na+
Fluxes

As found experimentally, activation of the b1-adrenergic
signaling system significantly increases the magnitude of intracellular [Ca2+]i transients, depending on the concentration of b1-ARs
agonist [75,127,128,129,139]. The effect is more pronounced in
rodent ventricular cells where the increase can reach up to 5 times
[127], and a smaller effect is observed in larger species, such as
rabbit and dog [139,140]. In addition to an increase in [Ca2+]i
transient amplitude, b1-AR agonists increase the rate of [Ca2+]i
decline.
There are several points of view on what is the major cause of
the inotropy and lusitropy in the heart. It is clear that
PLOS ONE | www.plosone.org

Our model of the b1-adrenergic signaling system in mouse
ventricular myocytes is able to reproduce experimental data on a
decrease in [Na+]i concentration upon activation of b1-ARs
(Fig. 20, [100,127]). We also estimated a contribution of the
different mechanisms of the Na+ entry and extrusion from the cell,
experimental data for which are not available yet. Simulations at
physiological frequency 5 Hz and without application of isoproterenol suggest that about 20% of Na+ enter the cell through the
fast Na+ current, 32% through the Na+/Ca2+ exchanger, and 48%
31

February 2014 | Volume 9 | Issue 2 | e89113

Adrenergic Signaling in Mouse Myocytes

through the background mechanisms (large Na+ gradient, the
Na+/H+ exchanger, the Na+/HCO23 co-transporter, etc.). With
application of isoproterenol, the fraction of Na+ entry decreases for
the fast Na+ current to 17%, increases to 46% for the Na+/Ca2+
exchanger, and decreases to 37% for the background mechanism.
These fractions are different from those estimated for the larger
species, such as rabbits [133]. For rabbits, about 22% of Na+ enter
the cell through the fast Na+ current (which is similar to our
estimations for mice), 60% through the Na+/Ca2+ exchanger, and
18% through the background mechanisms, suggesting the Na+/
Ca2+ exchanger to be the major player in the Na+ transport into
the cell. Further experiments are necessary to verify Na+ fluxes
structure in mouse ventricular cells without and with application of
isoproterenol estimated from the presented model.

two other, b2-adrenergic and CaMKII-mediated, signaling
systems that can potentially interact with the b1-adrenergic system.
Experimental data with mice shows that the b2-adrenergic
signaling system does not affect the b1-adrenergic system in
control and upon application of isoproterenol [7]. This phenomenon is explained by the significantly larger concentration of the
inhibitory G protein, Gi, compared to Gs in mouse ventricular
cells, which inhibits the stimulatory effects of the b2-ARs. The
effects of b2-ARs can only be revealed upon additional application
of pertussis toxin which suppresses the activity of Gi [7]. While the
effects of the CaMKII-mediated signaling system are not taken
into account in the presented model, the model of the
b1-adrenergic signaling system still describes reasonably well most
of the available experimental data on mouse ventricular myocytes.
The author considers this model as the first step in the development of a more comprehensive compartmentalized model of the
adrenergic signaling system in mouse ventricular myocytes.

Model Limitations
Despite that the presented model was extensively verified by the
experimental data and reproduced most effects which result from
stimulation of the b1-adrenergic signaling system, it has some
limitations. One of these limitations is that some experimental data
used for the model verification were obtained from different
species, such as rats, canine, and rabbits. In this respect, some of
the model parameters can be adjusted to fit the data obtained from
mouse ventricular myocytes, when such data becomes available. A
second source of the errors in model parameters is the low
accuracy of biochemical experiments, which can vary by an order
of magnitude (see for example data on PKA activation by cAMP).
However, investigations by Soltis and Saucerman [146] are very
encouraging about this issue. They have shown that the
b1-adrenergic signaling system is robust, at least in steady-state,
even when the model parameters change by 1–2 orders of
magnitude. Third, not all model parameters are measured directly
in the experiments, and, therefore, are adjusted numerically to fit
the experimental data downstream in the signaling pathway.
Finally, a fourth limitation comes from the availability of at least
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